STANDARD CURRICULUM VITÃ† FORMAT.doc.doc

Robert N. Taylor, MD, PhD

EMORY UNIVERSITY SCHOOL OF MEDICINESTANDARD CURRICULUM VITÆ FORMAT

Revised: May 2, 2005

1. Name: Robert N. Taylor, M.D., Ph.D.

2. Office Address: 1639 Pierce Drive, Suite 4217-WMBTelephone: 404-727-9106Fax: 404-727-8609

3. E-mail Address: [email protected]

4. Citizenship: USA

5. Current Titles and Affiliations: Professor, Department of Gynecology and Obstetrics, Emory University School of Medicine

a. Academic appointments:

I. Primary appointments:Vice Chair for Research, Department of Gynecology and Obstetrics, Emory University School of Medicine (May 2005)

II. Joint and secondary appointments:Professor, Department of Cell Biology, Emory University School of Medicine (May 2005)

b. Clinical appointments:

c. Other administrative appointments:Director of Research, Department of Gynecology and Obstetrics, Emory University School of Medicine (May 2005)

6. Previous Academic and Professional Appointments:

1984-85 Chief Resident in Obstetrics and Gynecology, U.C. San Francisco1985-86 Fellow in Reproductive Endocrinology, U.C. San Francisco (UCSF)1985-87 Visiting Scientist, Howard Hughes Medical Institute, UCSF 1987-91 Assistant Professor, Dept. of Obstetrics, Gynecology and Reproductive

Sciences, UCSF1991-97 Associate Professor, Dept. of Obstetrics, Gynecology and Reproductive

Sciences, UCSF1994-95 Visiting Scientist, INSERM U-135, Université de Paris XI, Le Kremlin-Bicêtre, France1997-2005 Professor, Dept. of Obstetrics, Gynecology and Reproductive Sciences, UCSF1986-2005 Active Medical Staff: UCSF Hospitals1987-2005 Member, UCSF Center for Reproductive Sciences 1991-2005 Member, Perinatal Medicine and Genetics Fellowship Program, UCSF 1991-2005 Member, Molecular Medicine Program, Professional Faculty, UCSF 1996-2005 Member, Biomedical Sciences Graduate Program, UCSF


7. Previous Administrative and/or Clinical Appointments:

Co-Director (1997-99) and Director, UCSF Reproductive Endocrinology and Infertility Fellowship Program (1999-2005)

Vice Chair for Research, Dept. of Obstetrics, Gynecology and Reproductive Sciences, UCSF (2000-2005)

Director, UCSF Division of Reproductive Endocrinology (1999-2001)Director, UCSF In Vitro Fertilization Program (1999-2001)Director, UCSF Center for Reproductive Sciences (2000-2005)UCSF General Clinical Research Center Advisory Committee (1994-2005), Chairman (1998-2005)Director, UCSF Women’s Reproductive Health Research (WRHR) Career Development Program

(2004-2005)

8. Licensures/Boards:

Medical Licensure: California C40648 (1981- )Texas G0192 (1981- )

9. Specialty Boards:

American Board of Obstetrics and Gynecology (certified December 1987, re-certified March 1997)American Board of Obstetrics and Gynecology, Division of Reproductive Endocrinology (certified December 1988, re-certified March 1997)

10. Education:

1967-71 St. Paul's School, Concord, New Hampshire (diploma cum laude, Clifford Gillespie, M.S.)

1971-75 Stanford University, Stanford, California (B.S. in Biological Sciences with Distinction and Honors, Errol C. Friedberg, M.D.)

1975-81 Baylor College of Medicine, Houston, Texas (M.D., Ph.D., Department of Cell Biology, Bert W. O’Malley, M.D. and Roy G. Smith, Ph.D.)

1981-86 University of California, San Francisco, California (Internship, Residency, and Chief Residency in Obstetrics and Gynecology; Fellowship in Reproductive Endocrinology, Robert B. Jaffe, M.D.)

11. Postgraduate Training:

University of California, San Francisco, Howard Hughes Medical Institute, San Francisco, California (Research Fellow in Cardiovascular Molecular Biology, Lewis T. Williams, M.D., Ph.D.) (1985-87)

Faculté de Médecine, Université de Paris XI, Unité de Recherches Hormones et Reproduction, Institut National de la Santé et de la Recherche Médicale, U135 Le Kremlin-Bicêtre, France (Visiting Scientist on sabbatical, Edwin Milgrom, M.D., D.Sc. and Jean-François Savouret, Ph.D.) (1994-95)

12. Military or Government Service: none


13. Committee Memberships:

a. National and International:

US National Institute of Child Health and Human Development (NICHD)Special Study Sections: Perinatal Emphasis Research Centers, October 1992, August 2001; PPG review, Reproductive Sciences Branch, October 1996; Chair, PPG review, Pregnancy and Perinatology Branch, October 1999, August 2000; Epidemiology Branch, May 2004, Intramural proposal review Developmental Endocrinology Branch, August 1998, extramural reviewer; Reproductive Scientist Development Program Executive Committee, 2001- ;Women’s Reproductive Health Research Career Development Centers: external reviewer (Univ. of Washington, June 2000, Univ. of Rochester, December 2002); Reproductive Endocrinology Study Section (ad hoc reviewer), February 2003, October 2003Integrative Clinical Endocrinology and Reproduction (ICER) Study Section (ad hoc reviewer), October 2004

Canadian Institutes of Health Research, Institute of Human Development, Child and Youth Health: grant reviewer, “Healthy Gametes and Great Embryos” August 2002

Belgian Fund for Research (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen), Brussels, Belgium: grant reviewer, February 1998, 1999, 2003, 2004

The Wellcome Trust, London, UK: grant reviewer, September 1998, March 1999, February 2004

Katholieke Universiteit Dienst Onderzoekscoördinatie, Leuven, Belgium: grant reviewer, April 1999

Fonds National Suisse de la Recherche Scientifique, Berne, Switzerland: grant reviewer, November 1999

Research Grants Council of Hong Kong, China: external assessor, January 2003Philip Morris External Research Program: grant reviewer, November 2003Australian National Health and Medical Research Council (NHMRC): external reviewer,

June 2004American Society for Reproductive Medicine, abstract review committee, 1996- , prize poster

selection committee, 2000- , research career development committee, 2000- , program committee member-at-large, 2004-

The Endocrine Society, Associates Council, 1998-2001American Board of Obstetrics and Gynecology, Division of Reproductive Endocrinology and

Infertility: oral examiner, April 1998, 2000Society for Reproductive Endocrinology and Infertility, Fellowship Committee, 1998- World Endometriosis Society: International Scientific Committee, July 1998- International Congress of Cell Biology of Reproduction: Organizing Committee, August 1999- Society for Gynecologic Investigation, abstract review committee, 1992- ;

Council, 2000-03; Website Development Committee 2001- ; Nominations Committee Chair, 2001-02; Corporate Advisory Committee, 2001- 03; Education Committee, 2002-2006

Endometriosis Zone Advisory Board, 2004- Faculty of 1000 Medicine “Reproductive Endocrinology” (www.f1000medicine.com), 2004

b. Regional and State:

UCSF California AIDS Research Center: external reviewer, January 2004California Institute for Regenerative Medicine: Scientific Standards Working Group, 2005-

http://www.f1000medicine.com/


c. Institutional

Dean's Panel on UCSF Housestaff and Fellows’ Research (1988-93)Dean’s Panel on Oocyte, Embryo and Stem Cell Research (OESCR) (2003-2005)UCSF School of Medicine Student Advisor Program (1990-94)UCSF Committee on Academic Promotion, ad hoc member (1990-2005)Review Committee, Burroughs-Wellcome Fund Career Awards (1998)UCSF General Clinical Research Center Advisory Committee (1994-2005), Chairman

(1998-2005)UCSF Academic Senate Committee on Equal Opportunity (2002-2005)Center for Reproductive Sciences Steering Committee (1988-2005)Obstetrics and Gynecology Research and Education Foundation, Scientific Review Committee (1995-2005), Board member (2000-2005)Endocrinology Grand Rounds Coordinating Committee (2004-2005)Department of Obstetrics, Gynecology and Reproductive Sciences

Residency Selection Committee (1985-96)Scientific Research Review Committee (1988- )Resident Research Day Coordinator (1991-97)Medical Student Advisor Program (1995-2005)Chair, Committee for Internal Academic Appointments (1996-2005)Reproductive Biology Group Advisory Board (1997-2005)Chair, Department Promotions Committee (1998-2002)Chair, Integrated Research Committee (1999-2005)

Search Committee for basic scientist, joint Molecular Medicine Program and Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF (1990)

Search Committee for Obstetrician/Gynecologist-Molecular Immunologist, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF, San Francisco General Hospital campus (1991)

Chair, Search Committee for Perinatologist-Developmental Biologist, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF (1992)

Co-chair, Search Committee for Menopause Endocrinologist, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF (1994)

Search Committee for Urogynecologist, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF (1998)

Search Committee for Gynecological Oncologist, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF, Mt. Zion Hospital campus (1998)

Chair, Search Committee for Director, Division of Perinatology and Genetics, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF (1999)

Chair, Search Committees for Reproductive Endocrinologist/IVF physician and IVF embryologist, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF (1999-2001)

Co-chair, Search Committee for Stem Cell Biologist, joint recruitment by the Center for Reproductive Sciences, Program in Biomedical Sciences, Program in Biological Sciences and Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF (2003)

Search Committee for Chair, Dept. of Obstetrics, Gynecology and Reproductive Sciences, UCSF (2004)

Search Committee for Reproductive Endocrinologist, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF, Mt. Zion Hospital campus (2004)


14. Consultantships:

Scientific Advisory Board, Adeza Biomedical, Sunnyvale, CA (1988- )Scientific Advisory Board, Arbogast Pharmaceuticals Inc., Johnson City, TN (1997- )Scientific Advisory Board, Procréa, Montréal, Canada (2000-2003)Chair, Scientific Advisory Board, Schering AG, Berlin, Germany (2003- )Medical Advisory Board, Valeo Medical, Inc., Princeton, NJ (2003- )Consultant, TAP Pharmaceutical, Chicago, IL (1999- )Consultant, Wyeth, Collegeville, PA (2003- )Consultant, Genentech, South San Francisco, CA (2004-2005)Consultant, Scios, Inc., Fremont, CA (2004- )Consultant, Otsuka America Pharmaceutical, Rockville, MD (2004- )

15. Editorships and Editorial Boards:

Associate EditorCurrent Problems in Obstetrics, Gynecology and Fertility (1996-2003)

Editorial BoardFaculty of 1000 Medicine “Reproductive Endocrinology” (www.f1000medicine.com) (2004- )Références en Gynécologie Obstétrique (1999-2003)Journal of Clinical Endocrinology and Metabolism (2005- )Journal of the Society for Gynecologic Investigation (2005- )

16. Manuscript reviewer:

American Journal of Hypertension (1999- )American Journal of Obstetrics and Gynecology (1990- )American Journal of Pathology (1998- )American Journal of Physiology (1990- )American Journal of Reproductive Immunology (1990- )Biology of Reproduction (1998- )Cancer Research (2002- )Clinical Chemistry (2002- )Contraception (2002- )Endocrine Reviews (1989- )Endocrine (2001- )Endocrinology (1999- )European Journal of Clinical Investigation (2002- )European Journal of Endocrinology (1999- )Fertility and Sterility (1996- )Gynecologic and Obstetric Investigation (2002- )Gynecological Endocrinology (1996- )Human Reproduction (1998- )Hypertension (1995- )Hypertension in Pregnancy (1992- )Immunology and Cell Biology (1997- )International Journal of Cancer (1999- )Journal of the American Medical Association (1988- )Journal of Clinical Endocrinology and Metabolism (1993- )Journal of Clinical Investigation (1991- )Journal of Endocrinological Investigation (1996- )

http://www.f1000medicine.com/


Journal of the Society for Gynecologic Investigation (1994- )Journal of Women’s Health (1999- )Lancet (1999- )Life Sciences (1999- )Molecular and Cellular Endocrinology (2001- )Molecular Endocrinology (1991- )Molecular Human Reproduction (1999- )Neuroendocrinology (1995- )Obstetrics and Gynecology (1986- )Oncogene (2001- )Peptides (1991- )Placenta (1990- )Prenatal Diagnosis (1991- )Proceedings of the National Academy of Sciences, USA (1990- )Regulatory Peptides (1996- )Steroids (2000- )Trends in Endocrinology and Metabolism (2000- )

17. Honors and Awards:

Undergraduate Honors Programs in Chemistry and Biological Sciences (Stanford University, 1971-75)

B.S. with Distinction and Honors (Depts. of Biological Sciences and Experimental Pathology, Stanford University, 1975)

Young Investigator Award (American Association for Clinical Chemistry, 1978) Medical Student Summer Fellowship: “Sex Steroid Receptors in Renal Tissue” (American

Urological Association, 1980)Outstanding Ob/Gyn Resident Award (American Fertility Society/Serono Laboratories, 1985)American College of Obstetricians and Gynecologists/Ortho Pharmaceutical Academic Training

Fellowship (ACOG, 1985-86)International Society for the Study of Hypertension in Pregnancy: Young Investigator Award (1990)Basil O'Connor Scholar Research Award #5-810, March of Dimes Birth Defects Foundation

(1990-93)Philippe Foundation Award for Franco-American Scientific Exchange (1994-95)UCSF Reproductive Endocrinology Fellows’ Teaching Award (1996)“500 Most-Trusted Physicians in the Bay Area” San Francisco Magazine, (2001)“America’s Top Doctors Guide” American Registry, Castle Connolly Medical Ltd. (2001- )“Guide to America’s Top Obstetricians and Gynecologists” Consumers’ Research Council of

America (2002- )“Leading Health Professionals of the World” International Biographical Centre, Cambridge, UK (2005)“United Who’s Who” Executives and Professionals (2005)“Who's Who in Medical Sciences Education” (2005)

18. Society Memberships:

American Association for the Advancement of Science (1990- )American Board of Obstetrics and Gynecology, Division of Reproductive Endocrinology and

Infertility: oral examiner, April 1998, 2000American College of Obstetricians and Gynecologists, Junior Fellow (1982-89), Fellow (1989- )American Gynecological and Obstetrical Society (2000- )American Society for Reproductive Medicine (formerly American Fertility Society) Associate

Member (1985-87), Member (1988- ), abstract review committee, (1996- ), prize poster


selection committee (2000-2004), research career development committee (2000- ), program committee member-at-large (2004- )

Bay Area Reproductive Endocrinology Society (1989-2005)Endometriosis Zone Advisory Board (2004- )International Congress of Cell Biology of Reproduction: Organizing Committee (1999- )International Society for the Study of Hypertension in Pregnancy (1991- )Society for Gynecologic Investigation (1989- ), abstract review committee (1992- ), Council

(2000-03), Website Development Committee (2001-03), Nominations Committee (2001, 2006), Corporate Advisory Committee (2001-03), Education Committee (2002- )

Society for Reproductive Endocrinology and Infertility (1989- ), Fellowship Committee (1998-2005)The Endocrine Society (1989- ), Associates Council (1998-2001)Wimberley Society (1980- )World Endometriosis Society (1998- ), Scientific Advisory Committee (2002- )

19. Organization of National or International Conferences:

a. Administrative positions:

Tox Talx Symposium on Preeclampsia, co-organizer, Mill Valley (1991, 1993, 1997, 1999, 2001, 2003, 2005)

b. Sessions as chair:

8th World Congress on Hypertension in Pregnancy, Buenos Aires: “Endocrine, paracrine and autocrine regulation of vascular tone during normal gestation” November 1992

75th Annual Meeting of the Endocrine Society, Las Vegas: “Fetal Placental Unit” June 199341st Annual Meeting of the Society for Gynecologic Investigation, Chicago: “Implantation” and

“Clinical Controversies in Endometriosis” March 199442nd Annual Meeting of the Society for Gynecologic Investigation, Chicago: “Immune Cell

Activation in Endometriosis” March 199551st Annual Meeting of the American Society for Reproductive Medicine, Seattle: “Cytokines

and Macrophages in Endometriosis” October 199552nd Annual Meeting of the American Society for Reproductive Medicine, Boston: “Clinical

Female Infertility” November 199645th Annual Meeting of the Society for Gynecologic Investigation, Atlanta: “Endometrium”

March 19981st Annual North American Society for the Study of Hypertension in Pregnancy,

Winston Salem: “Lipid Metabolism” July 199816th World Congress on Fertility and Sterility, San Francisco: “Reproductive Endocrinology”

October 19987th Congress of the European Society for Gynaecological Endoscopy, Lausanne:

“Endometriosis” December 199881st Annual Meeting of the Endocrine Society, San Diego: “Clinical Female Reproduction”

June 19992nd Annual North American Society for the Study of Hypertension in Pregnancy, Winston-

Salem: “Endothelial Cells and Lipids” July 199956th Annual Meeting of the American Society for Reproductive Medicine, San Diego:

Moderator, “Endometriosis” Seminar speaker, “Pathogenesis of Endometriosis: Bench to Bedside Innovations” Prize Poster Selection Committee, October 2000

8th International Society of Gynecological Endocrinology, Florence: Moderator, “Pathogenesis of Endometriosis” December 2000


57th Annual Meeting of the American Society for Reproductive Medicine, Orlando: Moderator, “Endometriosis” Symposium speaker, “Inflammation in Endometriosis” Prize Paper Presentation, October 2001

49th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles: Moderator, “Basic Reproductive Endocrinology” March 2002

6th International Congress on the Cell Biology of Reproduction, Cambridge, UK: Moderator, “Placental Biology” July 2002

58th Annual Meeting of the American Society for Reproductive Medicine, Seattle: Moderator, “Endometriosis” October 2002

59th Annual Meeting of the American Society for Reproductive Medicine, San Antonio: Workshop lecturer, “Endometriosis: Advances and Controversies” October 2003

51st Annual Meeting of the Society for Gynecologic Investigation, Houston: Moderator, “Clinical Reproductive Endocrinology and Infertility” March 2004

60th Annual Meeting of the American Society for Reproductive Medicine, Philadelphia: Workshop lecturer, “What’s New in Endometriosis: Pathophysiology” and Moderator, “Endometriosis” October 2004

52nd Annual Meeting of the Society for Gynecologic Investigation, Los Angeles: Moderator, “Fertilization and Implantation” March 2005

IXth World Congress on Endometriosis, Maastricht: Seminar leader “Inflammation and Immunology” September 2005 (scheduled)

20. Research focus:

My research focuses on the cellular and molecular biology of endometriosis. Our most important contributions include the establishment of a unique human endometriosis cell culture model and the demonstration that ovarian steroid hormones and macrophage-derived cytokines regulate lesion vascularization and proliferation. These insights have led to the identification of novel therapeutic targets and medications.

21. Patents

a. Issued:

“Diagnostic assay for the detection of preeclampsia” US Patent #5,238,819 issued on 24 August 1993

“Diagnostic assay for the prediction of preeclampsia” US Patent #5,712,103 issued on 27 January 1998

“Novel antiangiogenic peptide agents and their therapeutic and diagnostic use” #PCT/US98/09691, International application 98921156.0, U.S. Utility application 09/819,094, filed 27 March 2001

b. Pending: none

22. Grant Support:

a. Active support:

I. Federally funded:

1) NIH Award K12-HD01262: “Women’s Reproductive Health Research Center” Co-Program Director (A. Eugene Washington, M.D., M.Sc., P.I.), 5% effort (donated), 10/01/98-09/30/03, total direct costs $2,046,243;


Program Director (Elena Gates, M.D., P.I.), 10% effort, 05/15/04-05/14/09, total direct costs $1,998,811

2) NIH Award U54-HD37321: “Chemokine Regulation in Models of Endometriosis” Vanderbilt Uterine Biology Center, Co-I. (Kevin Osteen, Ph.D., Vanderbilt Univ., P.I.), 20% effort, 03/01/99-02/28/05, total direct costs for project $350,517

3) NIH Award T32-HD07162: “Graduate Research Training in Perinatal Biology” Assistant Program Director (Joseph A. Kitterman, M.D., P.I.), 5% effort (donated), 07/01/00-06/30/05, total direct costs $682,344

4) NIH Award R01-HL64145: “Copper/Albumin Redox-Cycling in Preeclampsia” Co-I. (Valerian E. Kagan, Ph.D., Univ. of Pittsburgh, P.I.), 10% effort, 12/01/00-11/30/04, total direct costs for subcontract $106, 014

5) NIH Award P01-HD40543: “Women’s HIV Pathogenesis Program” Laboratory Core Leader (Warner C. Greene, M.D., Ph.D., P.I.), 10% effort, 04/01/01-03/31/06, total direct costs $1,376,653

6) NIH Award R01 HL73469: “PPAR Function in Human Pregnancy and Preeclampsia” P.I., 15% effort, 04/01/03-03/31/06, total direct costs $649,824

7) NIH Award R01 HD44008: “Glycodelin Regulation in Polycystic Ovarian Syndrome” P.I., 25% effort, 04/01/03-03/31/07, total direct costs $720,000

8) NIH Award T32-HD07162: “Graduate Research Training in Perinatal Biology” Associate Program Director (Joseph A. Kitterman, M.D., P.I.), 5% effort (donated), 07/01/05-06/30/10, total direct costs $750,000

II. Private foundation funded:

Oracle Giving: “Cell Cycle Regulation in Endometriosis and Endometrial Cancer” p.1., 5% effort, 09/01/04-08/31/05, total direct costs $50,000

III. Contracts:

1) Pharmacia Research Contract MPAASV-V03-001 “Anti-Inflammatory Mechanisms of Medroxy-progesterone Acetate” P.I., 5% effort, 05/01/02-9/30/04, total direct costs $65,885

IV. Other:

b. Previous Support

1) NIH Award R01-HD18726: “Gonadal and Gonadotropin Regulation in the Fetus” Co-I. (Robert B. Jaffe, M.D., P.I.), 20% effort, 01/01/86-12/31/89, total direct costs $452,700

2) NIH FIRST Award R29-HD22873: “Trophoblast Proliferation and Growth Factor Expression” P.I., 50% effort, 06/01/87-05/31/93, total direct costs $339,104

3) NIH Award R01-HL39974: “HLA Regulation in Normal and Preeclamptic Trophoblasts” Co-I. (Elliott K. Main, M.D., P.I.), 5% effort, 04/01/88-03/31/93, total direct costs $582,898

4) NIH Award P01-HD24180: “Preeclampsia: Linkage to Placental Implantation-Perfusion” Co-P.I. (James M. Roberts, M.D., P.I., 05/01/88-04/30/92), P.I. (05/01/92-11/30/93), 20% effort, total direct costs $5,301,158

5) Obstetrics and Gynecology Research and Education Foundation Grant: “Biochemical Screening for Human Chromosomal Abnormalities” P.I., 5% effort, 11/01/89-10/31/90, total direct costs $9,850


6) Basil O'Connor Scholar Research Award #5-810, March of Dimes Birth Defects Foundation: “Growth Factor Regulation of Human Trophoblast Proliferation, Invasion and Differentiation” P.I., 10% effort, 09/01/90-04/30/93, total direct costs $67,000

7) Obstetrics and Gynecology Research and Education Foundation Grant: “Tissue Distribution of hCG-β Gene Expression During Human Fetal Development” P.I., 5% effort, 07/01/90-06/30/91, total direct costs $1,200

8) NIH Award P01-HD30367 (01-04) “Preeclampsia: Trophoblast and Endothelial Dysfunction” Co-I., (James M. Roberts, M.D., P.I.), 30% effort, 04/01/93-01/15/97, total direct costs $1,318,701

9) Philippe Foundation Grant for Franco-American Scientific Exchange “Progestin Regulation of Human Endometrial Gene Expression” P.I., 10% effort, 09/01/94-06/01/95, total direct costs $1,600

10) Women’s Health Research Institute Contract: “Development of Immortalized Cells from Endometrium” P.I., 5% effort, 05/01/97-04/30/98, total direct costs $41,248

11) UC BioSTAR Grant Application #S97-53: “Physiology and Pathophysiology of 16kD Lactogenic Hormones in the Human Placenta” P.I., 10% effort, 06/01/98-05/31/00, total direct costs $177,400

12) Women’s Health Research Institute Contract: “Identification of Endometriosis-Specific Gene Products” P.I., 5% effort, 09/01/98-08/31/00, total direct costs $58,336

13) NIH Award U01-AI34989 (supplement): “Effect of Gender and Ovulatory Cycle Phase on Viral Decay Rate in HIV-1 Infection” Co-I. (Ruth M. Greenblatt, M.D., P.I.), 5% effort, 12/01/99-11/30/00, total direct costs $176,293

14) NIH Award R01-HD33238: “Endometrial VEGF: Endocrine Regulation of Angiogenesis” P.I., 40% effort, 04/01/95-03/31/01, total direct costs $855,517

15) NIH Award U54-HD31398 (supplement): Specialized Cooperative Centers Program in Reproductive Research: “Gene Discovery in Human Endometrium and Endometriosis” Co-I. (Linda Giudice, Ph.D., M.D., Stanford Univ., P.I.), 5% effort, 04/01/00-03/31/02, total direct costs for subcontract $107,691

16) NIH Award P01-HD30367 (05-09): “Preeclampsia: Convergence of Fetal and Maternal Factors” Co-I. (James M. Roberts, M.D., Univ. of Pittsburgh, P.I.), 20% effort, 01/15/97-12/31/02, total direct costs $1,061,680 (project direct costs $509,033)

23. Clinical Service Contributions:

Directed UCSF Clinical Reproductive Endocrinology and Infertility program and In Vitro Fertilization program (1991-2001)

24. Formal Teaching:

a. Medical Student Teaching

“Hormones of Pregnancy” and “Early Development and its Disorders” UCSF Reproduction, Growth & Development, Interdisciplinary Sciences #135, Fall quarter (1987-2002), 120 students, 3 units

“Endometriosis, Recurrent Abortion and Ectopic Pregnancy” UCSF Obstetrics & Gynecology #110, all quarters (1987-2005), 5-9 students, 1.5 units


“Female Reproductive Physiology” UCSF Endocrinology and Gastrointestinal Physiology #101, section director and mini-course leader, Spring quarter (1989-2002), 120 students, 5 units

“Reproductive Medicine” UCSF Medical Scientist Training Program #160.04, Summer quarter (1991-2002), 20 students

“Postgraduate Training in Reproductive Medicine for MSTP Students” Joint UCSF and Stanford MSTP Retreat, San Francisco (May 1996)

“Obstetrics and Gynecology” UCSF Advances in Medical Sciences (Intersessions), quarterly (2001-2005), 10-12 students

Endocrinology Curriculum Committee, School of Medicine, UCSF (1998-2002)

b. Graduate Program

“Cellular Physiology of Placental Function” lecturer and section coordinator, Biology of Reproduction #230, Spring quarter (1988), 12 students, 2 units

“Uterine and Implantation Biology” lecturer and discussion leader, Molecular and Cellular Biology of Reproduction #210, Winter quarter (1993), 15 students, 4 units “Reproductive Biology Workshop” coordinator (1989-2001), one hour/week,15 post-docs and graduate students

Endocrinology Journal Club, four hours/month (1989-93), 12 post-docs and graduate studentsProgram in Biomedical Sciences Journal Club, one hour/month (1995- ), 25 graduate studentsGraduate Student Research Day, poster judge, 32 graduate student posters (1994- )“Hormone Analogues and Antagonists: Clinical Correlations” Physiology #121, School of

Pharmacy, 100 graduate students (1998- )“Reproduction, Development and Cell Specification” Biomedical Sciences #225A,

Program in Biomedical Sciences, five hours, 10 graduate students (2004- )

c. Postgraduate programs

Training programs

Reproductive Endocrinology Journal Club, Coordinator, one hour/week (1986-2002), 5-10 fellows, residents and students

Reproductive Endocrinology Workshop, Director, one hour/week (1995- ), 10 fellows, 10 facultyPerinatal Biosciences Review Course, Co-director, July/August (1991-2002), 5-10 clinical

fellows“Introduction to Molecular Genetics” discussion leader, Molecular Medicine #411,

Summer quarter (1991-94), 5-10 postdocsCo-Director, UCSF Reproductive Endocrinology Fellowship Program (1997-99)Director, UCSF Reproductive Endocrinology and Infertility Fellowship Program (1999- )UCSF Endocrinology Fellowship Programs’ review course, Reproductive Endocrinology

section leader (1997- ), 5-10 fellows and postdocs

Residency program

Attending physician in General Gynecology, two months/year (1986-88), one month/year (1989-2001) 5-10 students and residents

Team Meeting, case discussions, one hour/week (1986- 2001), 5-10 students and residentsRotating presentations in Basic Science Lecture Series, 15 students, residents, and fellows:

“Molecular Approaches to Reproductive Failure” “The Ovary: Gamete and Hormone Production” “Endometriosis: Pathophysiology and Management”


“Ectopic Pregnancy: Advances in Diagnosis and Therapy” “Mechanisms of Implantation and Recurrent Abortion” Resident Research Day, Coordinator (1991-98, except 1995), 32 residents, 10 students, 24 fellows and faculty

25. Supervisory Teaching:

a. Ph.D. students directly supervised:

Barbara A. Foster (1988-95) “Mesenchymal-epithelial interactions during prostate development” (Ph.D. qualifying exam and thesis committees, UCSF Program in Biomedical Sciences) Assistant Professor, Baylor College of Medicine

Robin Covello (1989) “Biology of mouse placental lactogen II” (Ph.D. qualifying exam committee, Dept. of Biology, U.C. Santa Cruz) Scientist, Genentech Inc.

Jah-Yao Liu, M.D. (1989-92) “Role of PGE2 in myometrial contractility” (Ph.D. thesis committee, UCSF Endocrinology Program), Chair, Dept. of Obstetrics and Gynecology, University Hospital of Taiwan

Dori H. Nakahara (1990) “Regulation of signal sequence degradation” (Ph.D. qualifying exam committee, UCSF Endocrinology Program)

Elizabeth A. Vitalis (1992-2000) “Role of the cAMP pathway in pituitary tumorigenesis” (Ph.D. qualifying exam and thesis committees, UCSF Endocrinology/Biomedical Sciences Program)

Iris Roth (1993) “Cytokine expression in human trophoblast differentiation” (Ph.D. qualifying exam committee, UCSF Program in Biomedical Sciences) Senior Scientist, Scios Inc.

Mary Janatpour (1993) “Role of intracellular pH in the differentiation of cytotrophoblasts” (Ph.D. qualifying exam committee, UCSF Program in Biomedical Sciences) Senior Scientist, Chiron, Inc.

Christian Vaisse, M.D. (1994-95) “Caractérisation du gène humain codant pour la protéine endometriale PP14” (Président, Ph.D. thesis committee, Biochimie et Biologie Moléculaire, Université de Paris XI) Associate Professor, Dept. of Medicine, U.C. San Francisco

Hsinyu Lee (1994-96) “Role of 16 kDa prolactin as an anti-angiogenic factor” (Ph.D. qualifying exam committee, UCSF Program in Biomedical Sciences)

Eric C. Person (1999-2000) “Effects of serum proteins on PPAR ligand action” (Ph.D. candidate advisor, UCSF Graduate Program in Biophysics)

Zhigang Yu (2001-04) “Arachidonic acid metabolism and soluble epoxide hydrolase in blood pressure regulation” (Ph.D. qualifying exam and thesis committees, UCSF Graduate Program in Biopharmaceutical Sciences) Scientist, Merck Inc.

Tommi Vaskivuo (2002) “Regulation of apoptosis in the female reproductive system” (Ph.D. thesis First Opponent, Medical Faculty of the University of Oulu, Finland, Department of Obstetrics and Gynecology) Assistant Professor, Dept. of Obstetrics and Gynecology, University of Oulu

Winnie Young Kim (2002-04) “Modulation of P-glycoprotein expression and function by sex-steroid hormones” (Ph.D. thesis committee, UCSF Graduate Program in Biopharmaceutical Sciences) Scientist, Amgen Inc.

Torun Clausen, M.D. (2000-02) “Maternal and placental factors and risk of preeclampsia ” (Dr. Med. thesis First Opponent, University of Oslo, Norway, Department of Obstetrics and Gynecology and Institute for Nutrition Research) Assistant Professor of Obstetrics and Gynecology, University of Oslo


b. Post-doctoral fellows directly supervised:

Thomas J. Musci, M.D. (1987-89) Perinatology fellow. “Growth factor expression in preeclampsia” NICHD/AGOS Reproductive Scientist Training Program fellowship recipient, Director of Perinatal Research, California Pacific Medical Center, San Francisco

Paula A. Rothman, M.D. (1989-91) Reproductive Endocrinology fellow. “Analysis of fetal kidney hCG synthesis” Private practice, Atlanta

Paul G. Kratzer, M.D., Ph.D. (1988-93) Visiting scientist. “Placental regulation of corpus luteum function in normal and aneuploid pregnancies” Private practice, Sacramento

Sarah J. Kilpatrick, M.D., Ph.D. (1990-92) Perinatology fellow. “Molecular characterization of endothelin binding sites and function in the developing human placenta” Chair, Dept. of Obstetrics & Gynecology, University of Illinois, Chicago

Valerie L. Baker, M.D. (1990-95) Resident and Reproductive Endocrinology Fellow; ACOG/Mead-Johnson and ACOG/Ortho Training Fellowship “Sex steroid and autacoid modulation of placental blood flow” Private practice, Palo Alto

Isabelle P. Ryan, M.D. (1991-97) Combined track Resident and Reproductive Endocrinology Fellow/Junior faculty; American Fertility Society/Serono Reproductive Medicine Fellowship, ACOG/Ortho Training Fellowship, Berlex Scholarship “Cellular mechanisms of reduced fecundity in endometriosis” Private Practice, San Francisco

Christianne J.M. de Groot, M.D. (1991-93) Postdoctoral fellow; Ter Meulen Fund Fellowship (Royal Netherlands Academy of Arts and Sciences) “Regulation of autacoid gene expression in cultured human endothelial cells” Associate Professor of Obstetrics and Gynecology, University of Rotterdam

Steven A. Friedman, M.D. (1991-93) Perinatology fellow. “Markers of maternal and fetal endothelial cell injury in preeclampsia” Private practice, Portland

Kee-Hak Lim, M.D. (1992-95) Perinatology fellow/Junior faculty; Society of Perinatal Obstetricians and AAOGF Fellowship. “Phospholipase A2 activity and eicosanoid metabolism in preeclampsia” Associate Professor of Obstetrics and Gynecology, Harvard Medical School

Jan L. Shifren, M.D. (1993-96) Reproductive Endocrinology fellow/Junior faculty; ACOG/Ortho Training Fellowship and AAOGF Fellowship recipient. “Angiogenesis in endometrium and endometriosis” Associate Professor of Obstetrics and Gynecology, Harvard Medical School

Eugene Muzykanskiy, M.D. (1994-96) Visiting scientist. “Abnormalities of lipid metabolism in women with preeclampsia” private practice, Chicago

Russell A. Foulk, M.D. (1994-96) Reproductive Endocrinology fellow. “Thyrotropic activity of human chorionic gonadotropin” Private practice, Reno

Daniela Hornung, M.D. (1995-97, 1999-2001) Postdoctoral fellow/Visiting Scientist (University of Tübingen); Deutsche Forschungsgemeinschaft and Fortune Project Fellowship recipient “Regulation of chemokine expression in endometriosis” Privat Dozent, Gynecology, University of Lübeck

Dan I. Lebovic, M.D., M.A. (1996-2001) Reproductive Endocrinology fellow/Junior faculty. “Regulation of angiogenesis and inflammation in endometriosis” NIH NRSA Postdoctoral Fellowship F32-HD08517 “Role and regulation of VEGF in endometriosis” Assistant Professor of Obstetrics and Gynecology, University of Michigan

Frauke Bentzien, M.D., Ph.D. (1996-2001) Postdoctoral fellow; Cowell Foundation Fellowship recipient. “Regulation of human placental angiogenesis” Senior Scientist, Excelexis, Inc.

Janet Burlingame, M.D. (1996-98) Perinatology fellow. “Genetic disorders of long-chain fatty acid metabolism in preeclampsia” Private practice, Cleveland


Alfred W. Brandenberger, M.D. (1997-98) Visiting scientist (University of Berne); Swiss National Foundation Fellowship “Estrogen receptor isoforms in endometrial tissues and cells” Private practice, Zug, Switzerland

Leslie L. Waite, Ph.D. (1998-2003) Postdoctoral fellow; Cowell Foundation Fellowship and NIH NRSA Postdoctoral Fellowship F32-HD08567 “PPAR-γ activation of endothelial and trophoblast cells in preeclampsia” Assistant Research Biochemist, U.C. San Francisco

Michael D. Mueller, M.D. (1998-2000) Visiting scientist (University of Berne); Swiss National Foundation Fellowship. 1st Prize, 2000 Swiss Society for Gynecology and Obstetrics Research Award, Privat Dozent “VEGF regulation in endometrial tissues and cells” Associate Professor of Obstetrics and Gynecology, University of Berne

Victor R. Suarez, M.D. (1998-99) Visiting postdoctoral fellow (Loyola University, Chicago). “TNF-α in preeclampsia and human cell cultures”

Capt. Catherine Takacs, M.D. (1998- ) Ob/Gyn resident (Grant Medical Center, Travis Air Force Base). “Immunologic dysregulation in women with endometriosis”

Jane Grimwood, Ph.D. (1999-2000) Assistant Research Endocrinologist. “Angiogenic growth factor expression in preeclampsia” Assistant Professor, Stanford Genome Center

Stephanie Mann, M.D. (2000-04) Assistant Professor, NIH Clinical Associate Physician, GCRC; Pfizer/Society for Women’s Health Research Faculty Development Award. “Molecular mechanisms of amniotic fluid regulation” Assistant Professor, Residency Program Coordinator, Phoenix

Elizabeth A. Pritts, M.D. (2000-02) Reproductive Endocrinology fellow. “Immune modulation in endometriosis using PPAR-γ ligands” Assistant Professor, University of Wisconsin

Dong Zhao, M.D. (2000-02) Postdoctoral fellow. “RANTES gene regulation in endometriosis cells by progestins and dioxin” Graduate student, University of Wisconsin

Gwo-Jang Wu, M.D., Ph.D. (2001) Visiting Scientist (Tri-Services General Hospital, Taiwan) “New developments in assisted reproductive technology” Associate Professor, University Hospital, Taiwan

Marco Buttarelli, M.D. (2001) Visiting Scientist (Università de Varese, Italy) “Environmental endocrine disruptors in reproductive medicine” Assistant Professor, Università de Varese

Louis L. Peeters, M.D., Ph.D. (2001-02) Visiting Scientist (Sabbatical) (Academic Hospital Maastricht, The Netherlands). “Fatty acid regulation of endometrial angiogenesis” Professor, Academic Hospital Maastricht

Sireesha Reddy, M.D., (2001- ) Women’s Reproductive Health Research scholar and K23 award applicant (University of Rochester) external advisor for “Immune modulation by CD40 in endometriotic stromal cells” Assistant Professor of Obstetrics and Gynecology, University of Rochester

Danielle Lane, M.D. (2002-2004) Reproductive Endocrinology fellow. “Dysregulation of glycodelin gene expression in women with polycystic ovary syndrome” Assistant Professor, UCSF

Friedrich Wieser, M.D. (2003- ) Visiting scientist (University of Vienna); Erwin Schrödinger Fellowship recipient, Austrian Science Foundation (FWF). “Inflammatory mechanisms in endometriosis.” Research Instructor, Emory University

Karen J. Purcell, M.D., Ph.D. (2003- ) Reproductive Endocrinology fellow. “Environmental toxicants in reproductive failure” Senior fellow, UCSF

Phyllis Chihping Tien, M.S., M.D. (2004- ) Assistant Adjunct Professor and K23 applicant. “Gender effects of HIV on lipodistrophy and metabolism” Assistant Professor, Department of Medicine, UCSF


c. Residency Program

Omid A. Khorram, M.D., Ph.D. (1992-93) Resident. “Peritoneal fluid cytokine concentrations in endometriosis” ACOG/Ortho Training Fellowship recipient, Associate Professor of Obstetrics and Gynecology, Harbor-UCLA School of Medicine

Dale C. Leitman, M.D., Ph.D. (1995-97) Ob/Gyn resident. “Transcriptional regulation of cytokine genes in human endometrial cells” Associate Professor of Obstetrics and Gynecology and Cellular and Molecular Pharmacology, U.C. San Francisco

Ededet Udo, M.D. (1998-99) Ob/Gyn resident. “Transcriptional regulation of TNF-α gene expression in human monocytes and peritoneal macrophages” Private practice, New York

O.W. Stephanie Yap, M.D. (1999-2004) Ob/Gyn resident. “Mechanisms of progestin and androgen action on mediators of inflammation” WRHR Scholar, Assistant Professor, Morehouse University

Lorenza Driul, M.D. (1999) Visiting Ob/Gyn resident (Università de Udine, Italy). “Cytokines in ovarian physiology” Assistant Professor, Università de Udine

Carla Burks-Wicks, M.D. (2003- ) Ob/Gyn resident. “Complementary and alternative medical approaches in endometriosis” Resident, UCSF

d. Other

Erin D. Newman (1987-88) “Human trophoblast cytodifferentiation in vitro”Mark R. Taylor (1987-89) “Analysis of fetal and placental hCG-β isoforms”Martin E. Edep (1989) “Morphological evidence of endothelial cell activation in

preeclampsia” (March of Dimes Medical Student Summer Fellowship)Laura M. Goetzl (1990) “Effects of preeclamptic serum on endothelin production in

human endothelial cells” (March of Dimes Medical Student Summer Fellowship)Jennifer F. Tseng (1993-95) “Estrogen regulation of a novel cytokine in endometriosis”

(Howard Hughes Training Fellowship for Medical Students; 1995 UCSF Dean’s Award for Medical Student Research)

Ellen S. Moore (1996) “Cytokines and endometriosis” (Einstein University School of Medicine Summer Student Fellowship)

Gordon Wilson (1999) “Studies in molecular reproductive biology” (Enterprise for High School Students Career Exploration Program)

Amy K. Atwood (2001) “Metabolic derangement in preeclampsia” (University of Sydney School of Medicine Research Elective)

Rachel Bolden-Kramer (2001) “PPAR activation by pregnancy serum factors” (Science and Health Education Partnership Summer Student, co-mentored with Leslie Waite, Ph.D.)

Jonathan Li (2002) “Viral and immunologic characteristics of long term survivors in a Chinese HIV+ population” (medical student, UCSF Doris Duke Clinical Fellow / GCRC Mentor Committee)

Natalia Dvorak (2002-03) “Aquaporin expression in human placenta and fetal membranes” (pre-medical student, Smith College)

Catherine Brissaud (2003) “Clinical investigation in reproductive medicine” (medical student, Université Claude Bernard, Institut Laënnec, Lyon, France)

Natalie Young (2003) “Predictive serum analytes for preeclampsia” (pre-medical student, Amherst College)

Miori Tomisaka (2004) “Clinical investigation in reproductive medicine” (medical student, Juntendo University, Yokohama/Tokyo, Japan)

Adrienne Baillet (2004) “Experimental approaches in reproductive physiology” (graduate student, Institut Pierre et Marie Curie, Université de Paris VII, France)


Schima Djalali (2004) “Progesterone resistance in endometriosis” (medical student, University of Vienna, Austria)

Lars-Uwe Klöckl (2005) “Research in Reproductive Sciences” (undergraduate student, Schwerin, Germany, EF International School of English, Mills College)

26. Lectureships, Seminar Invitations, and Visiting Professorships:

“Effects Ovulatory Hormones and Chemokine Production on HIV Viral Load in Women” Presented at the N.I.H. Conference on Gender and HIV Viral Load, San Francisco, January 2000

“Endometriosis and Infertility: Pathogenesis” Obstetrics and Gynecology Grand Rounds, University of Wisconsin, Madison, April 2000

“Angiogenesis in Human Endometrium and Endometriosis” International Conference on the Female Reproductive Tract, Frauenwörth, May 2000

“Genomic and Proteomic Approaches to Cellular Pathology” VII World Congress on Endometriosis, London, May 2000

“Endometriosis: An Inflammatory Paradigm” WRHRDC Symposium, University of Washington, Seattle, June 2000

“Preeclampsia: Etiology and Mechanisms” Obstetrics and Gynecology Grand Rounds, University of Louisville, Louisville, June 2000

“Endometriosis: Inflammation and Infertility” 8th World Congress of Gynecological Endocrinology, Florence, December 2000

“Endometrial angiogenesis” Seminari della Scuola di Specializzazione, Università de Siena, December 2000

“Bioactive Lipids and the Pathogenesis of Preeclampsia” Seminar in Toxicology and Environmental Sciences, University of Pittsburgh, Pittsburgh, February 2001

“Endometriosis: Inflammation and Infertility” Distinguished Lectureship, Brigham and Women’s Hospital, Harvard Medical School, Boston, February 2001

“Angiogenic Factors in Endometriosis” N.I.H. Conference on Endometriosis: Emerging Research and Intervention Strategies, NICHD, Bethesda, April, 2001

“Endometriosis: An Inflammatory Paradigm” 1st Nordic Congress on Endometriosis, Stockholm, April 2001

“Sex Steroids and RANTES β-Chemokine Production” N.I.H. Conference on Gender Effects in HIV Biology, NICHD, Bethesda, June 2001

“Regulation of PPARs by Albumin: Relevance to Preeclampsia” 6th Tox Talx Symposium on Preeclampsia, Mill Valley, July 2001

"Inflammatory Factors In Endometriosis" European Society for Human Reproduction and Embryology, Lausanne, July 2001

“Succeeding in Academics” NIH/SREI: Fellows’ Retreat on Career Development, Aspen, August 2001“Gender and HIV: Sex, Steroids and Immune Regulation” Directors’ Research Seminar Series,

UCSF Center for AIDS Research, October 2001“Chemokine Expression in Endometrium and Endometriosis” 9th World Congress on

Gynecological Endocrinology, Hong Kong, December 2001“Role of Genomics in the Understanding of Endometriosis Pathophysiology” VIIIth World Congress

on Endometriosis, San Diego, February 2002“Angiogenesis in Endometriosis” Society for Gynecologic Investigation Postgraduate Course,

Los Angeles, March 2002“Inflammation in Endometriosis” 6th International Congress on the Cell Biology of Reproduction,

Cambridge, UK, July 2002“Pathophysiology of Endometriosis” Ob/Gyn Seminar, University of Oslo, September 2002“Endocrine Basis of Reproductive Failure” ASRM 35th Annual Postgraduate Course, Seattle,

October 2002“Endocrine Aspects of Endometriosis” Endocrinology Grand Rounds, UCSF, November 2002


“Angiogenesis in Endometriosis” University of Rochester Women’s Reproductive Health Research Symposium, Rochester, December 2002

“Immune Activation in Endometriosis” Chicago Area Reproductive Endocrinology Society, Chicago, June 2003

“Immunology and Endometriosis” Ob/Gyn Grand Rounds, Yale University, New Haven, June 2003“Endometriosis: Advances and Controversies” ASRM 59th Annual Meeting, San Antonio, October 2003“Current Concepts and Controversies in Hormone Replacement Therapy” Postgraduate Program

XVI, ASRM 59th Annual Meeting, San Antonio, October 2003“Hormone and Cytokine Regulation of Angiogenesis in Endometriosis: Basic and Clinical Implications”

University of Illinois Bed-to-Bedside Symposium, Champaign-Urbana, October 2003“Vascular Pathophysiology of the Preeclampsia Syndrome” Gyn/Ob Grand Rounds, Emory

University, December 2003“Disorders of Angiogenesis in Women’s Health” Research Seminar, University of Münster,

Germany, February 2004“Placental Angiogenesis in Physiology and Pathophysiology” 11th World Congress on

Gynecological Endocrinology, Florence, February 2004“Endothelial Cell Markers as Indicators of Preeclampsia Risk” Research Seminar, Scios Inc.,

Foster City, March 2004“Endometriosis: A Common Trait Linked with Immune Polymorphisms” NIH Symposium on

Reproductive Biology: Intersections with HIV Research, Women’s HIV Interdisciplinary Network, San Francisco, May 2004

“Overview of Vascular Physiology and Pathophysiology in Pregnancy” GCRC Research Symposium, Massachusetts Institute of Technology, Boston, May 2004

“Endometriosis: Cell Biology, Genetics and Genomics” Massachusetts General Hospital Ob/Gyn Grand Rounds, Harvard Medical School, Boston, May 2004

“Preeclampsia: Presentation and Mechanisms” Beth Israel-Deaconess Hospital Perinatology Rounds, Harvard Medical School, Boston, May 2004

“Endometriosis: Pathophysiology and Drugable Targets” Research Seminar, Schering AG, Berlin, June 2004

“What’s New in Endometriosis? Nuclear Receptors” Symposium, American Society for Reproductive Medicine, Philadelphia, October 2004

“Human Embryonic Stem Cells: Roles of the Obstetrician-Gynecologist” Kenneth J. Ryan Lecture, American College of Obstetricians and Gynecologists, San Francisco, May 2005 (planned)

“Inflammatory Responses in Endometriosis” IXth World Congress on Endometriosis, Maastricht, September 2005 (planned)

“Nuclear Receptor Actions in Endometriosis” 12th World Congress on Gynecological Endocrinology, Florence, March 2006 (planned)

27. Invitations to National or International Conferences:

American College of Obstetricians and Gynecologists, Annual Meeting, San Francisco (2005)American Gynecological and Obstetrical Society, Williamsburg (2000), Napa (2003), Bolton

Landing (2004)American Fertility Society/American Society for Reproductive Medicine, San Diego (2000),

Orlando (2001), Seattle (2002), San Antonio (2003), Philadelphia (2004)Berlex Foundation Scholars’ Symposium, Sonoma (2003)European Society for the Human Reproduction and Embryology, Lausanne (2001), Berlin (2004)International Conference on the Endometrium, New York (2000)International Conference on the Female Reproductive Tract, Frauenchiemsee (2000)International Society of Gynecological Endocrinology, Florence (2000), Hong Kong (2001),

Florence (2004)International Society for the Study of Hypertension in Pregnancy, Paris (2000), Vienna (2004)


Nordic Congress on Endometriosis, Stockholm (2001)N.I.H. Conference on Physician-Scientist Career Development, NICHD, Aspen (2001)N.I.H. Conference on Gender and HIV Viral Load, NIAID, San Francisco (2000)N.I.H. Conference on Endometrial Function and Dysfunction (Specialized Cooperative Centers

Program in Reproduction Research), Palo Alto (2000)N.I.H. Conference on Endometriosis: Emerging Research and Intervention Strategies, NICHD,

Bethesda (2001)N.I.H. Women’s HIV Interdisciplinary Network, Seattle (2002), Chicago (2003), San Francisco (2004)N.I.H. MACS/WIHS Aging Cohorts Meeting, Bethesda (2004)N.I.H. MACS/WIHS Joint Meeting, San Francisco (2004)2nd N.I.H. International Congress: Advances in Uterine Leiomyoma Research, Bethesda (2005)Society for Gynecologic Investigation, Chicago (2000), Toronto (2001), Los Angeles (2002),

Washington (2003), Houston (2004), Los Angeles (2005)Society of Perinatal Obstetricians/Society for Maternal and Fetal Medicine, San Francisco (2003),

Reno (2005)Society for Reproductive Endocrinology and Infertility: Fellows’ Retreat on Career Development,

Aspen (2001), Park City (2004, 2005)The Endocrine Society, Toronto (2000), San Francisco (2002), Philadelphia (2003), New Orleans

(2004)Tox Talx Symposium on Preeclampsia, Mill Valley (2001, 2003, 2005)Wimberley Society, Wimberley (2003)World Congress on Endometriosis, London (2000), San Diego (2002), Maastricht (2005)

28. Other Activities:

Visiting Professor: University of Wisconsin, Madison, April 2000Visiting Professor: University of Washington, Seattle, June 2000Visiting Professor: University of Louisville, Louisville, June 2000Visiting Professor, Università di Siena, Siena, Italy, December 2000Visiting Professor, Brigham and Women’s Hospital, Boston, February 2001Visiting Professor, University of Pittsburgh, February 2001Visiting Professor, Karolinska Institute, Stockholm, April 2001Visiting Professor, Tokyo Medical University, Tokyo, January 2002Visiting Professor, University of Oulu, Faculty of Medicine, Finland, May 2002Visiting Professor, New Jersey Medical School, Newark, May 2002Visiting Professor, University of Oslo, Faculty of Medicine, Norway, September 2002Visiting Professor, University of Rochester, Rochester, December 2002Visiting Professor, Georgetown University, Washington, February 2003Visiting Professor, University of California, Fresno Medical Center, April 2003Visiting Professor, Stanford University School of Medicine, May 2003Visiting Professor, University of Illinois, Chicago, June 2003Visiting Professor, Yale University, New Haven, June 2003, January 2004Visiting Professor, University of Illinois-Urbana Campus, October 2003Visiting Professor, Emory University, Atlanta, December 2003Visiting Professor, University of Münster, Germany, February 2004Visiting Professor, Harvard Medical School, May 2004Visiting Professor, University of Vienna, Faculty of Medicine, November 2004


29. Bibliography:

a. Published and accepted research articles (clinical, basic science, other) in refereed journals:

1. Minton K, Durphy M, Taylor R and Friedberg E. Ultraviolet endonuclease of bacteriophage T4: Further characterization. J Biol Chem 250:2823-2829, 1975

2. Pawl G, Taylor R, Minton K and Friedberg E. Enzymes involved in thymine dimer excision in bacteriophage T4-infected E. coli. J Mol Biol 108:99-109, 1976

3. Smith RG, Clarke SG, Zalta E and Taylor RN. Two estrogen receptors in reproductive tissue. J Steroid Biochem 10:31-35, 1979

4. Taylor RN and Smith RG. Pure estrogen receptor complexes stimulate RNA transcription in vitro. Biochem Biophys Res Commun 91:136-142, 1979

5. Taylor RN, Swaneck GE and Smith RG. Correlation of nuclear acceptor sites for estrogen receptors with gene transcription in vitro. Biochem J 292:385-393, 1980

6. Smith RG and Taylor RN. Estrogen receptors as mediators of gene transcription. J Steroid Biochem 15:321-328, 1981

7. Taylor RN and Smith RG. Identification of a novel sex steroid binding protein. Proc Natl Acad Sci USA 79:1742-1746, 1982

8. Taylor RN and Smith RG. Effects of highly purified estrogen receptors on gene transcription in isolated nuclei. Biochemistry 21:1781-1787, 1982

9. Taylor RN, Welch KL, Sklar DM, McKerrow JH and Creasy RK. Heterotopic skin in the uterus. J Reprod Med 29:837-840, 1984

10. Taylor RN and Smith RG. Correlation in isolated nuclei of template engaged RNA polymerase II, ovalbumin mRNA, and estrogen receptor concentrations. Biochemistry 24:1275-1280, 1985

11. Taylor RN, Bottles K, Miller TR and Braga CA. Malignant fibrous histiocytoma of the vulva. Obstet Gynecol 66:145-148, 1985

12. Taylor RN, Lacey CG and Shuman MA. Adenocarcinoma of Skene's duct associated with a systemic coagulopathy. Gynecol Oncol 22:250-256, 1985

13. Bottles K and Taylor RN. Aspiration cytology diagnosis of breast masses in pregnant and lactating patients. Obstet Gynecol 66:76-78, 1985

14. Taylor RN and Sonson RD. Separation of the pubic symphysis: An under-recognized peripartum complication. J Reprod Med 31:203-206, 1986

15. Taylor RN and Green JR. Abruptio placentae following nipple stimulation. Am J Perinatol 4:94-97, 1987

16. Taylor RN, Padula C and Goldsmith PC. Pitfall in the diagnosis of ectopic pregnancy: Immunocytochemical evaluation in a patient with false-negative serum βhCG levels. Obstet Gynecol 71:1035-1038, 1988

17. Taylor RN and Williams LT. Developmental expression of platelet-derived growth factor and its receptor in the human placenta. Mol Endocrinol 2:627-632, 1988

18. Rodgers GM, Taylor RN and Roberts JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelium. Am J Obstet Gynecol 159:908-914, 1988

19. Musci TJ, Roberts JM, Rodgers GM and Taylor RN. Mitogenic activity is increased in the sera of preeclamptic women prior to delivery. Am J Obstet Gynecol 159:1446-1451, 1988

20. Taylor RN, Musci TJ, Kuhn RW and Roberts JM. Partial characterization of a novel growth factor from the blood of preeclamptic women. J Clin Endocrinol Metab 70:1285-1291, 1990

21. Kratzer PG and Taylor RN. Corpus luteum function in early pregnancies is primarily determined by the rate of change of human chorionic gonadotropin levels. Am J Obstet Gynecol 163:1497-1502, 1990


22. Taylor RN, Varma M, Teng NNH and Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71:1675-1677, 1990

23. Taylor RN, Heilbron DC and Roberts JM. Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am J Obstet Gynecol 163:1839-1843, 1990

24. Taylor RN, Musci TJ, Rodgers GM and Roberts JM. Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression in human endothelial cell cultures. Am J Reprod Immunol 25:105-108, 1991

25. Kratzer PG, Golbus MS, Finkelstein DE and Taylor RN. Trisomic pregnancies have normal human chorionic gonadotropin bioactivity. Prenat Diagn 11:1-6, 1991

26. Taylor RN, Newman ED and Chen S. Forskolin and methotrexate induce an intermediate trophoblast phenotype in cultured human choriocarcinoma cells. Am J Obstet Gynecol 164:204-210, 1991

27. Kratzer PG, Golbus MS, Monroe SE, Finkelstein DE and Taylor RN. First trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free αhCG, and progesterone. Prenat Diagn 11:751-763, 1991

28. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC and Roberts JM. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 165:895-901, 1991

29. Taylor RN, Casal DC, Jones LA, Varma M, Martin JN Jr and Roberts JM. Selective effects of preeclamptic sera on human endothelial cell procoagulant protein expression. Am J Obstet Gynecol 165:1705-1710, 1991

30. Malee MP, Malee KM, Azuma SD, Taylor RN and Roberts JM. Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia. J Clin Endocrinol Metab 74:1095-1100, 1992

31. Roberts JM, Edep ME, Goldfien A and Taylor RN. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: Morphological and biochemical evidence. Am J Reprod Immunol 27:101-108, 1992

32. Rothman PA, Chao VA, Taylor MR, Kuhn RW, Jaffe RB and Taylor RN. Extraplacental human fetal tissues express mRNA transcripts encoding the human chorionic gonadotropin-β subunit protein. Mol Reprod Devel 33:1-6, 1992

33. Friedman SA, de Groot CJM, Taylor RN and Roberts JM. Circulating concentrations of fetal fibronectin do not reflect reduced trophoblastic invasion in preeclamptic pregnancies. Am J Obstet Gynecol 167:496-497, 1992

34. Kratzer PG, Golbus MS, Schonberg SA, Heilbron DC and Taylor RN. Cytogenetic evidence for selective loss of trisomy 21 pregnancies with advancing maternal age. Am J Med Genet 44:657-663, 1992

35. Kilpatrick SJ, Roberts JM, Lykins DL and Taylor RN. Characterization and ontogeny of endothelin receptors in human placenta. Am J Physiol 264 (Endocrinol Metab 27):E367-372, 1993

36. Varma M, de Groot CJM, Lanyi S and Taylor RN. Evaluation of plasma insulin-like growth factor binding protein-3 as a potential predictor of preeclampsia. Am J Obstet Gynecol 169:995-999, 1993

37. Khorram O, Taylor RN, Ryan IP, Schall TJ and Landers DV. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 169:1545-1549, 1993

38. Friedman SA, de Groot CJM, Taylor RN, Golditch BD and Roberts JM. Plasma cellular fibronectin as a measure of endothelial cell involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 170:838-841, 1994


39. Ryan IP, Schriock ED and Taylor RN. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab 78:642-649, 1994

40. Bass KE, Morrish D, Roth I, Bhardwaj D, Taylor RN, Zhou Y and Fisher SJ. Human cytotrophoblast invasion is upregulated by epidermal growth factor: Evidence that paracrine factors modify this process. Dev Biol 164:550-561, 1994

41. Sudhir K, MacGregor JS, DeMarco T, de Groot CJM, Taylor RN, Chou TM, Yock PG and Chatterjee K. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries. Circulation 90:3018-3023, 1994

42. de Groot CJM, Davidge ST, Friedman SA, McLaughlin MK, Roberts JM and Taylor RN. Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in enzyme mass or activity. Am J Obstet Gynecol 172:976-985, 1995

43. Lim K-H, Rice GE, de Groot CJM and Taylor RN. Plasma type II phospholipase A2 levels are elevated in severe preeclampsia. Am J Obstet Gynecol 172:998-1002, 1995

44. de Groot CJM, Chao VA, Roberts JM and Taylor RN. Human endothelial cell morphology and autacoid expression. Am J Physiol 268 (Heart Circul Physiol 37):H1613-1620, 1995

45. Ryan IP, Tseng JF, Schriock ED, Khorram O, Landers DV and Taylor RN. Interleukin (IL)-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 63:929-932, 1995

46. Sudhir K, DeMarco T, Kumar S, Maganti K, Amidon TM, de Groot CJM, Klinski C, Lau D, Keith F, Taylor RN and Chatterjee K. Transcoronary and pulmonary vascular dynamics of endothelin-1 in heart transplant recipients. J Heart Lung Transpl 14:230-235, 1995

47. Tseng JF, Ryan IP, Milam TD, Murai JT, Schriock ED, Landers DV and Taylor RN. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 81:1118-1122, 1996

48. Darney PD, Taylor RN, Klaisle C, Bottles K and Zaloudek C. Serum concentrations of estradiol, progesterone and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users. Contraception 53:97-100, 1996

49. de Groot CJM, O’Brien TJ and Taylor RN. Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to develop preeclampsia. Am J Obstet Gynecol 175:24-29, 1996

50. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB and Taylor RN. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81:3112-3118, 1996

51. Arbogast BW, Leeper SC, Merrick RD, Olive KE and Taylor RN. Plasma factors that determine endothelial cell lipid toxicity in vitro correctly identify women with preeclampsia in early and late pregnancy. Hypertens Pregnancy 15:263-279, 1996

52. Hornung D, Ryan IP, Chao VA, Vigne J-L, Schriock ED and Taylor RN. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab 82:1621-1628, 1997

53. de Groot CJM, Merrill DC, Taylor RN, Kitzmiller JL, Goldsmith PC and Roberts JM. Increased von Willebrand factor expression in an experimental model of


preeclampsia produced by reduction of uteroplacental perfusion pressure in conscious rhesus monkeys. Hypertens Pregnancy 16:177-185, 1997

54. Foulk RA, Musci TJ, Schriock ED and Taylor RN. Does human chorionic gonadotropin have human thyrotropic activity in vivo? Gynecol Endocrinol 11:195-201, 1997

55. Murai JT, Muzykanskiy E and Taylor RN. Maternal and fetal modulators of lipid Metabolism correlate with the development of preeclampsia. Metabolism 46:963-967, 1997

56. Taylor RN, Ryan IP, Moore ES, Hornung D, Shifren JL and Tseng JF. Angiogenesis and macrophage activation in endometriosis. Ann NY Acad Sci 828:194-207, 1997

57. Vigne J-L, Murai JT, Arbogast BW, Jia W, Fisher SJ and Taylor RN. Elevated non-esterified fatty acid concentrations in severe preeclampsia shift the isoelectric characteristics of plasma albumin. J Clin Endocrinol Metab 83:3786-3792, 1997

58. Baker VL, Chao VA, Murai JT, Zaloudek CJ and Taylor RN. Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors. J Soc Gynecol Invest 4:316-324, 1997

59. de Groot CJM, Murai JT, Vigne J-L and Taylor RN. Eicosanoid secretion by human endothelial cells exposed to normal pregnancy and preeclampsia plasma in vitro. Prostaglandins Leukot Essent Fatty Acids 58:91-97, 1998

60. Shifren JL, Mesiano S, Taylor RN, Ferrara N and Jaffe RB. Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells. J Clin Endocrinol Metab 83:1342-1347, 1998

61. Hornung D, Lebovic DI, Shifren JL, Vigne J-L and Taylor RN. Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil Steril 69:909-915, 1998

62. Baker VL, Murai JT and Taylor RN. Down-regulation of protein kinase C by phorbol ester increases expression of epidermal growth factor receptors in transformed trophoblasts and amplifies human chorionic gonadotropin production. Placenta 19:475-482, 1998

63. Taylor RN, Savouret J-F, Vaisse C, Vigne J-L, Ryan I, Hornung D, Seppälä M and Milgrom E. Promegestone (R5020) and mifepristone (RU486) both function as progestational agonists of human glycodelin gene expression in isolated human epithelial cells. J Clin Endocrinol Metab 83: 4006-4012, 1998

64. Brandenberger AW, Lebovic DI, Tee MK, Ryan IP, Tseng JF, Jaffe RB and Taylor RN. Oestrogen receptor (ER)-α and ER-β isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod 5:651-655, 1999

65. Greenblatt RM, Ameli N, Grant RM, Bacchetti P and Taylor RN. Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women. J Infect Dis 181:82-90, 2000

66. Lebovic DI, Bentzien F, Chao VA, Garrett E, Meng YG and Taylor RN. Activation of an angiogenic phenotype in human endometriosis stromal cells by interleukin-1β. Mol Hum Reprod 6:269-275, 2000

67. Taylor RN, Vigne J-L, Zhang P, Hoang P, Lebovic DI and Mueller MD. Effect of progestins and relaxin on glycodelin gene expression in human endometrial cells. Am J Obstet Gynecol 182:841-849, 2000

68. Mueller MD, Lebovic DI, Garrett E and Taylor RN. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril 74:107-112, 2000


69. Hornung D, Dohrn K, Sotlar K, Greb RR, Wallwiener D, Kiesel L and Taylor RN. Localization in tissues and secretion of eotaxin by cells of normal endometrium and endometriosis. J Clin Endocrinol Metab 85:2604-2608, 2000

70. Lebovic DI, Shifren JL, Ryan IP, Mueller MD, Korn AP, Darney PD and Taylor RN. Ovarian steroid and cytokine modulation of endometrial angiogenesis. Hum Reprod 15 (Suppl 3): 67-77, 2000

71. Waite LL, Person EC, Zhou Y, Lim K-H, Scanlan TS and Taylor RN. Placental peroxisome proliferator-activated receptor γ is upregulated by human pregnancy serum. J Clin Endocrinol Metab 85: 3808-3814, 2000

72. Mueller MD, Vigne J-L, Minchenko AG, Lebovic DI, Leitman DC and Taylor RN. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci USA 97:10972-10977, 2000

73. Hornung D, Fujii E, Lim K-H, Vigne J-L McMaster MT and Taylor RN. Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril 75:814-817, 2001

74. Person EC, Waite LL, Taylor RN and Scanlan TS. Serum albumin inhibits induction of peroxisome proliferator-activated receptor- by 15-deoxy-∆12,14-prostaglandin J2. Endocrinology 142:551-556, 2001

75. Hornung D, Bentzien F, Kiesel L, Wallwiener D and Taylor RN. Chemokine bioactivity in normal endometrial and endometriotic stromal cells and peritoneal fluid. Mol Hum Reprod 7:163-168, 2001

76. Hornung D, Waite LL, Ricke EA, Bentzien F, Wallwiener D and Taylor RN. Nuclear peroxisome proliferator-activated receptors α and γ have opposing effects on monocyte chemotaxis in endometriosis. J Clin Endocrinol Metab 86:3108-3114, 2001

77. Hornung D, Klingel K, Dohrn K, Kandolf R, Wallwiener D and Taylor RN. Regulated on activation, normal T-cell-expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: Assessment of autocrine/paracrine regulation by in situ hybridization. Am J Pathol 158:1949-1954, 2001

78. Vigne J-L, Hornung D, Mueller MD and Taylor RN. Purification and characterization of an immunomodulatory endometrial protein: Glycodelin. J Biol Chem 276:17101-17105, 2001

79. Lebovic DI, Chao VA, Martini J-F and Taylor RN. Interleukin-1β induction of RANTES (regulated upon activation normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on an NF-κB site in the proximal promoter. J Clin Endocrinol Metab 86:4759-4764, 2001

80. Tyurin VA, Liu S-X, Tyurina YY, Sussman NB, Hubel CA, Roberts JM, Taylor RN and Kagan VE. Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ Res 88:1210-1215, 2001

81. Pritts EA, Zhao D, Ricke EA, Waite LL and Taylor RN. PPAR-γ decreases endometrial stromal cell transcription and translation of RANTES in vitro. J Clin Endocrinol Metab 87:1841-1844, 2002

82. Zhao D, Lebovic DI and Taylor RN. Long-term progestin treatment inhibits RANTES gene expression in an in vitro model of endometriosis. J Clin Endocrinol Metab 87:2514-2519, 2002

83. Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Osteen KG, Taylor RN, Lessey BA and Giudice LG. Global gene profiling in human endometrium during the window of implantation. Endocrinology 143:2119-2138, 2002

84. Zhao D, Pritts EA, Chao VA, Savouret J-F and Taylor RN. Dioxin stimulates RANTES production in an in vitro model of endometriosis. Mol Hum Reprod 8:849-854, 2002

85. Taylor RN, Lundeen SG and Giudice LC. Emerging role of genomics in endometriosis research. Fertil Steril 78:694-698, 2002


86. Lebovic DI, Baldocchi RA, Mueller MD and Taylor RN. Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses. Fertil Steril 78:849-854, 2002

87. Hornung D, Chao VA, Wallwiener D and Taylor RN. Thiazolidinediones, agonisten des PPAR-γ-rezeptors (Peroxisomaler Proliferator-Aktivierter Rezeptor), reduzieren die peritoneale makrophagenanzahl. Neue medikamentöse therapieoptionen für die inflammation und infertilität bei endometriose? Geburtsh Frauenheilk 9: 882-886, 2002

88. Mann SE, Ricke EA, Torres EA, Yang B, Verkman AS, Taylor RN. Expression and localization of aquaporin 1 and 3 in human fetal membranes. Am J Obstet Gynecol 187:902-907, 2002

89. Mueller MD, Vigne J-L, Pritts EA, Chao V, Dreher E and Taylor RN. Progestins activate vascular endothelial growth factor (VEGF) gene transcription in endometrial adenocarcinoma cells. Fertil Steril 79:386-392, 2003

90. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ and North RA. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathological pregnancies. Am J Obstet Gynecol 188:177-182, 2003

91. Mueller MD, Mazzucchelli L, Buri C, Lebovic DI, Dreher E and Taylor RN. Epithelial neutrophil-activating peptide 78 (ENA-78) concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 79:815-820, 2003

92. Hornung D, Chao VA, Vigne J-L, Wallwiener D and Taylor RN. Thiazolidinedione (TZD) inhibition of peritoneal inflammation. Gynecol Obstet Invest 55:20-24, 2003

93. Gryzunov YA, Arroyo A, Vigne J-L, Zhao Q, Tyurin VA, Hubel CA, Gandley RE, Vladimirov YA, Taylor RN and Kagan VE. Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants. Arch Biochem Biophys 413:53-66, 2003

94. Easwaran V, Lee S-H, Inge L, Guo L, Goldbeck S, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman S, Taylor RN and Fantl WJ. β-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 63:3145-3153, 2003

95. Mueller MD, Pritts EA, Zaloudek CJ, Dreher E and Taylor RN. Regulation of vascular endothelial growth factor by tamoxifen in vitro and in vivo. Gynecol Obstet Invest 55:119-124, 2003

96. Pritts EA, Zhao D, Sohn SH, Chao VA, Waite LL and Taylor RN. Peroxisome-proliferator activated receptor (PPAR)-γ ligand inhibition of RANTES production in human endometriotic stromal cells is mediated by an upstream promoter element. Fertil Steril 80:415-420, 2003

97. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA and Giudice LC. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144:2870-2881, 2003

98. Tulac S, Nayak N, Kao LC, van Waes M, Huang J, Lobo S, Germeyer A, Lessey BA, Taylor RN, Suchanek E and Giudice LC. Identification, characterization and regulation of the canonical wnt signaling pathway in human endometrium. J Clin Endocrinol Metab 88:3860-3866, 2003

99. Thadhani R, Mutter W, Wolf M, Levine R, Taylor RN, Sukhatme V, Ecker J and Karumanchi SA. First trimester sFlt-1 and placental growth factor and risk for preeclampsia. J Clin Endocrinol Metab 89: 770-775, 2004

100. Lebovic DI, Chao VA and Taylor RN. Peritoneal macrophages induce RANTES chemokine gene expression in endometrial stromal cells. J Clin Endocrinol Metab 89:1397-1401, 2004


101. Lo B, Chou V, Cedars MI, Gates E, Taylor RN, Wolf L, Wagner RM and Yamamoto KR. Informed consent in human oocyte, embryo and stem cell research. Fertil Steril 82:559-563, 2004

102. Gandley RE, Tyurin VA, Huang W, Arroyo A, Daftary A, Harger G, Jiang J, Taylor RN, Hubel CA, and Kagan VE. S-Nitroso-albumin-mediated relaxation is enhanced by ascorbate and copper: Implications for impaired vascular function in preeclampsia. Hypertension 45:21-27, 2005

103. Krikun G, Schatz F, Taylor RN, Critchley HOD, Rogers PA, Huang STJ and Lockwood CJ. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab, in press, 2005

104. Waite LL, Louie RE and Taylor RN. Circulating activators of PPARs are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab, 90:620-626, 2005

105. Pritts EA, Ryan IP, Mueller MD, Lebovic DI, Shifren JL, Zaloudek CJ, Korn AP, Darney PD and Taylor RN. Angiogenic effects of Norplant® contraception on endometrial histology and bleeding. J Clin Endocrinol Metab, 90:2142-2147, 2005

106. Wieser F, Dogan S, Klingel K, Diedrich K, Taylor RN and Hornung D. Expression and regulation of CCR-1 in peritoneal macrophages from women with and without endometriosis. Fertil Steril, in press, 2005

107. Yie SM, Taylor RN and Librach CL. Low plasma HLA-G concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol, in press, 2005

108. Wolf M, Shah A, Martinez A, Smirnakis K, Levine RH, Taylor RN, Ecker JL, Karumanchi SA and Thadhani R. Circulating levels of angiogenesis markers differ in first versus second pregnancies. Am J Obstet Gynecol, in press, 2005

109. Wieser F, Vigne J-L, Wenzl R, Huber J and Taylor RN. Effects of phorbol dibutyrate (PDB) on cell proliferation, apoptosis and TNF-α expression in human endometrial adenocarcinoma cells. J Soc Gynecol Invest, in press, 2005

110. Mueller MD, Vigne J-L, Streit M, Tee M-K, Raio L, Dreher E, Bersinger NA and Taylor RN. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases glycodelin gene and protein expression in human endometrium. J Clin Endocrinol Metab, in press, 2005

b. Manuscripts submitted:

1. Cejtin HE, Kim S, Taylor RN, Watts DH, Minkoff HL, Massad LS, Preston-Martin S, Anastos K and Moxley M. Menopause in the HIV-positive woman. JAIDS, submitted, 2005

2. Peeters LLH, Waite LL, Vigne J-L, Tee M-K, Zhao D and Taylor RN. PPAR- activation represses VEGF expression in human endometrial cells: Implications for uterine angiogenesis. J Clin Endocrinol Metab, in revision, 2005

3. Kim W, Taylor RN, Bacchetti P, Benet LZ and Frassetto L. Effects of HIV viral infection and menstrual cycle on nelfinavir pharmacokinetics in premenopausal women. JAIDS, submitted, 2005

4. Lo B, Zettler P, Cedars MI, Gates E, Taylor RN, Wagner RM, Wolf LE, Wuerth M and Yamamoto KR. California’s Proposition 71: A new era in the ethics of Human Embryonic Stem Cell Research, N Engl J Med, submitted

c. Review articles:

1. Patton P and Taylor RN. Endometriosis: New insights into an enigmatic disorder. West J Med 148:325-326, 1988

2. Taylor RN. Ectopic pregnancy and reproductive technology. JAMA 259:1862-1864, 1988


3. Taylor RN. Risk factors for ectopic pregnancy [letter reply]. JAMA 260:1555, 1988

4. Taylor RN and Callen KR. Common problems in office gynecology: Vulvovaginitis. Mod Med 56:72-76, 1988

5. Taylor RN and Callen KR. Common problems in office gynecology: Abnormal vaginal bleeding. Mod Med 56:77-80, 1988

6. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rodgers GM and McLaughlin MK. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 161:1025-1034, 1989

7. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA and McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 161:1200-1204, 1989

8. Roberts JM and Taylor RN. Lack of association of cytotoxicity in serum and preeclampsia (letter reply). Am J Obstet Gynecol 162:873-874, 1990

9. Roberts JM and Taylor RN. Preeclampsia: An endothelial cell disorder plus “something else” (letter reply). Am J Obstet Gynecol 163:1366, 1990

10. Roberts JM, Taylor RN, Friedman SA and Goldfien A. New developments in pre-eclampsia. Fetal Med Rev 2:125-141, 1990

11. Kratzer PG and Taylor RN. Nonsurgical treatment of tubal pregnancy (letter). Fertil Steril 55:1020-1021, 1991

12. Roberts JM, Taylor RN and Goldfien A. Endothelial cell activation as a pathogenetic factor in preeclampsia. Sem Perinatol 15:86-93, 1991

13. Roberts JM, Taylor RN and Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4:700-708, 1991

14. Taylor RN. Endometriosis: Current concepts in management. Audio-Digest Foundation, Obstetrics/Gynecology 38:5, California Medical Association, 1991

15. Taylor RN, Friedman SA and Roberts JM. Preeclampsia: An endothelial cell disorder (letter reply). Am J Obstet Gynecol 166:769-770, 1992

16. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA and McLaughlin MK. Pre-eclampsia: A disorder of the endothelial cells? Gynäkologe 25:2-6, 1992

17. de Groot CJM and Taylor RN. New insights into the etiology of pre-eclampsia. Ann Med 25:243-249, 1993

18. Taylor RN, Hill JA and Goldberg JD. Recurrent spontaneous abortion. ACOG Educational Program: Update 19:6, American College of Obstetricians and Gynecologists, 1993

19. Arbogast BW, Leeper SC, Merrick RD, Olive KE and Taylor RN. Which plasma factors bring about disturbance of endothelial function in pre-eclampsia? Lancet 343:340-341, 1994

20. Gordon JD, Shifren JL, Foulk RA, Taylor RN and Jaffe RB. Angiogenesis in the human female reproductive tract. Obstet Gynecol Surv 50:688-697, 1995

21. Roberts JM, Hubel CA and Taylor RN. Endothelial dysfunction yes, cytotoxicity no! Am J Obstet Gynecol 173:978-979, 1995

22. Taylor RN. Lightning and fattening: Evolving concepts in the pathophysiology of preeclampsia. West J Med 164:359-361, 1996

23. Taylor RN, Cadieux MM, Givens CR and Schriock ED. Infertility treatment. Audio-Digest Foundation, Obstetrics/Gynecology 43:18, California Medical Association, 1996

24. de Groot CJM and Taylor RN. Preeclampsia: An update. Eur J Obstet Gynecol Reprod Biol 67:59-60, 1996

25. Taylor RN. Review: Immunobiology of preeclampsia. Am J Reprod Immunol 37:79-86, 1997

25. Ryan IP and Taylor RN. Endometriosis and infertility: New concepts. Obstet Gynecol Surv 52:365-371, 1997


26. McMaster MT, Lim K-H and Taylor RN. Immunobiology of human pregnancy. Curr Probl Obstet Gynecol Fertil 21:7-23, 1998

27. Taylor RN, de Groot CJM, Cho YK and Lim K-H. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol 16:17-31, 1998

28. Lebovic DI, Mueller MD and Taylor RN. Vascular endothelial growth factor in reproductive biology. Curr Opin Obstet Gynecol 11:255-260, 1999

29. Taylor RN. Book Review: Estrogens and Progestogens in Clinical Practice. Fraser IS, Jansen RPS, Lobo RA and Whitehead MI, eds, Churchill Livingstone, London, 1998. Fertil Steril 72:757, 1999

30. Taylor RN, Mueller MD, Vigne J-L and de Groot CJM. Pathogénèse vasculaire du syndrome pré-éclamptique—éclamptique. Référ Gynécol Obstét 67:297-303, 1999

31. Taylor RN and Greenblatt RM. Sex and shedding of human immunodeficiency virus (letter reply). J Infect Dis182:376, 2000

32. Mueller MD, Dreher E and Taylor RN. Auf den spur eines rätsels: Angiogenese und endometriose. Geburtsch Frauenheilk 60:585-593, 2000

33. Taylor SB and Taylor RN. Album Review: Beatin' the Heat. Dan Hicks and the Hot Licks. Launch vol. 44, September 2000, Santa Monica

34. Mueller MD, Vigne J-L, Vaisse C and Taylor RN. Glycodelin: A pane in the implantation window. Semin Reprod Med 18:289-298, 2000

35. Lebovic DI, Mueller MD and Taylor RN. Immunobiology of endometriosis. Fertil Steril 75:1-10, 2001

36. Vigne J-L, Mueller MD, Vaisse C and Taylor RN. Production et biologie de la glycodéline dans l'endomètre. Référ Gynécol Obstét 8:32-40, 2001

37. Taylor RN, Lebovic DI, Hornung D and Mueller MD. Endocrine and paracrine regulation of endometrial angiogenesis. Ann NY Acad Sci 943:109-121, 2001

38. Taylor RN, Lebovic DI and Mueller MD. Angiogenic factors in endometriosis. Ann NY Acad Sci 955:89-100, 2002

39. Seppälä M, Taylor RN, Koistinen H, Koistinen R and Milgrom E. Glycodelin: A major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23:401-430, 2002

40. Waite LL, Atwood AK and Taylor RN. Preeclampsia, an implantation disorder. Rev Endocr Metab Disord 3:151-158, 2002

41. Lo B, Chou V, Cedars MI, Gates E, Taylor RN, Wolf L, Wagner RM and Yamamoto KR. Consent from donors for embryo and stem cell research. Science 301:921, 2003

42. Taylor RN and de Groot CJM. Pre-eclampsia and vascular activation in women and non-human primates. Gynecol Obstet Invest 57:38-40, 2004

43. Taylor RN. The future of endometriosis research: genomics and proteomics? Gynecol Obstet Invest 57:47-49, 2004

44. Taylor RN and Mueller MD. Anti-angiogenic treatment of endometriosis: Biochemical aspects. Gynecol Obstet Invest 57:54-56, 2004

45. Wieser F, Wenzl R, Taylor RN, Diedrich K and Hornung D. Genetik der endometriose. Gynäkologe 8:676-680, 2004

46. Burks-Wicks C, Cohen M, Fallbacher J, Taylor RN, Wieser F. A western primer of Chinese herbal therapy in endometriosis and infertility. J Women’s Health, submitted

d. Symposium contributions:


e. Book chapters:

1. Smith RG and Taylor RN. Estrogen receptors as mediators of gene transcription. In: Recent Advances in Steroid Biochemistry, vol. 5. Pasqualini JR and Scholler R, eds, Pergamon Press, London, pp 321-328, 1982

2. Martin MC, Taylor RN and Hoffman PE. The Endocrinology of Pregnancy. In: Basic and Clinical Endocrinology, 3rd edition. Greenspan FS, ed, Appleton & Lange, San Mateo, pp 543-568, 1990

3. Friedman SA, Taylor RN and Roberts JM. Pathophysiology of Preeclampsia. In: Clinics in Perinatology. Sibai BM, ed, WB Saunders, Philadelphia, pp 661-682, 1991

4. de Groot CJM and Taylor RN. Role of Endothelium in Pregnancy and in Pregnancy-Related Diseases. In: Current Obstetric Medicine, vol 2. Lee RV, Barron WM, Cotton DB and Coustan DR, eds, Mosby-Year Book, Chicago, pp 107-137, 1993

5. Martin MC, Taylor RN and Kitzmiller JL. The Endocrinology of Pregnancy. In: and Clinical Endocrinology, 4th edition. Greenspan FS and Baxter JD, eds, Appleton & Lange, Norwalk, pp 525-550, 1994

6. Bass KE, Morrish D, Roth I, Bhardwaj D, Taylor RN, Zhou Y and Fisher SJ. Epidermal Growth Factor Regulates Human Cytotrophoblast Invasion. In: Molecular and Cellular Aspects of Periimplantation Processes. Dey SK, ed, Springer-Verlag, New York, pp 303-317,1995

7. Taylor RN and Martin MC. The Endocrinology of Pregnancy. In: Basic and Clinical Endocrinology, 5th edition. Greenspan FS and Strewler GJ, eds, Appleton & Lange, Norwalk, pp 548-574, 1997

8. Lim K-H and Taylor RN. Endothelial Cell Dysfunction in Pre-eclampsia. In: New Horizons in Reproductive Medicine. Coutifaris C and Mastroianni L, eds, Parthenon, Carnforth, pp 507-519, 1997

9. Taylor RN. Pre-eclampsia as a Vascular Disorder. In: Revolutionizing Women’s Healthcare- A Consensus Conference. Medical Education Collaborative, Golden, pp 40-43, 1998

10. Taylor RN, Ryan IP, Tseng JF, Shifren JL, Hornung D and Lebovic DI. Ovarian Steroids and Angiogenesis. In: Understanding Endometriosis: Advances in Research and Practice. Lemay A and Maheux R, eds, Parthenon, Carnforth, pp 131-137, 1999

11. Taylor RN and Roberts JM. Endothelial Cell Dysfunction. In: Chesley’s Hypertensive Disorders of Pregnancy, 2nd edition. Lindheimer MD, Cunningham FG and Roberts JM, eds, Appleton & Lange, Norwalk, pp 395-429, 1999

12. Ryan IP, Moore ES and Taylor RN. Cytokines in Endometriosis. In: Cytokines in Reproduction. Hill JA, ed, John Wiley & Sons, New York, pp 259-285, 2000

13. Taylor RN, Lebovic DI and Martin-Cadieux MC. The Endocrinology of Pregnancy. In: Basic and Clinical Endocrinology, 6th edition. Greenspan FS and Gardner DG, eds, McGraw-Hill, New York, pp 575-602, 2001

14. Mueller MD and Taylor RN. Angiogenesis in Endometriosis. In: Vascular Morphogenesis in the Female Reproductive System. Augustin H, Iruela-Arispe L, Rogers P and Smith S, eds, Birkhäuser, Boston, pp 245-270, 2001

15. Taylor RN. Preeclampsia. In: The Endometrium. Glasser SR, Aplin J, Giudice LC and Tabibzadeh S, eds, Taylor & Francis, London, pp 604-625, 2002

16. Taylor RN, Hornung D, Mueller MD and Lebovic DI. Immunology of Endometriosis. In: Infertility and Reproductive Medicine Clinics of North America. Arici A, ed, WB Saunders, Philadelphia, pp 145-157, 2002

17. Pritts EA and Taylor RN. Endometriosis. In: Female Reproductive Endocrinology. Rebar RW, ed, www.endotext.org, MDText.com, Inc., 2002

http://www.endotext.org/


18. Lebovic DI, Hornung D, Mueller MD and Taylor RN. Immunologic Factors in Endometriosis. In: Immunology and Allergy Clinics of North America. Arici A, ed, WB Saunders, Philadelphia, pp 585-598, 2002

19. Taylor RN and Lebovic DI. The Endocrinology of Pregnancy. In: Basic and Clinical Endocrinology, 7th edition. Greenspan FS and Gardner DG, eds, McGraw-Hill, New York, pp 637-657, 2003

20. Pritts EA and Taylor RN. An Evidence-Based Evaluation of Endometriosis-Associated Infertility. In: Endocrinology and Metabolism Clinics of North America. Berga SL, ed, WB Saunders, Philadelphia, pp. 653-667, 2003

21. Taylor RN. Endometriosis. In: Yen and Jaffe’s Reproductive Endocrinology. 5th edition. Barbieri RL and Strauss JF III, eds, Harcourt, Philadelphia, pp 691-711, 2004

22. Purcell CJ, Taylor RN and Lingappa VR. Disorders of the Female Reproductive Tract. In: Pathophysiology of Disease: An Introduction to Clinical Medicine. 5th edition. McPhee SJ, Lingappa VR and Ganong WF, eds, McGraw-Hill, New York, in press, 2005

23. Taylor RN and Lebovic DI. The Endocrinology of Pregnancy. In: Basic and Clinical Endocrinology, 8th edition. Gardner DG and Shoback D eds, McGraw-Hill, New York, in preparation, 2005

f. Books edited and written:

1. Arbogast BW and Taylor RN. Molecular Mechanisms of Preeclampsia. Landes, Austin, 1996

2. Lebovic DI, Gordon JD and Taylor RN. Reproductive Endocrinology and Infertility: Handbook for Clinicians. Scrub Hill Press, Arlington, in press, 2005

g. Book reviews:

1. Taylor RN. Book Review: Estrogens and Progestogens in Clinical Practice. Fraser IS, Jansen RPS, Lobo RA and Whitehead MI, eds, Churchill Livingstone, London, 1998. Fertil Steril 72:757, 1999

h. Manuals, videos, computer programs, and other teaching aids:

1. Taylor RN. Endometriosis: Current concepts in management. Audio-Digest Foundation, Obstetrics/Gynecology 38:5, California Medical Association, 1991

2. Taylor RN, Hill JA and Goldberg JD. Recurrent spontaneous abortion. ACOG Educational Program: Update 19:6, American College of Obstetricians and Gynecologists, 1993

3. Taylor RN, Cadieux MM, Givens CR and Schriock ED. Infertility treatment. Audio-Digest Foundation, Obstetrics/Gynecology 43:18, California Medical Association, 1996

i. Other publications:

Theses:

1. Taylor RN. In Vivo Kinetics of Pyrimidine Dimer Excision by T4 Ultraviolet Endonuclease. B.S. Honors Thesis, Departments of Biological Sciences and Experimental Pathology, Stanford University, Stanford, California, 1975

2. Taylor RN. Molecular Mediators of Estrogen-Regulated Gene Transcription. Ph.D. Thesis, Department of Cell Biology, Baylor College of Medicine, Houston, Texas, 1981


Published abstracts

1. Pawl G, Taylor RN and Friedberg EC. Kinetics of thymine dimer excision from phage T4 DNA in vivo. Biophys J 16:58A, 1976. Presented at the 20th Annual Biophysical Society Meeting, Seattle, February 1976

2. Taylor RN. Pitfalls in the quantitation of estrogen receptors. Presented at the American Association for Clinical Chemistry (Texas section), Austin, October 1978

3. Taylor RN, Swaneck GE and Smith RG. Ovalbumin gene transcription and estrogen receptor concentration. #63. Presented at the 20th National Student Research Forum, Galveston, April 1979

4. Taylor RN, Smith RG and Swaneck GE. Purified estrogen-receptor complexes stimulate RNA transcription in vitro. #776. Presented at the 61st Annual Endocrine Society Meeting, Anaheim, June 1979

5. Taylor RN, Swaneck GE and Smith RG. Correlation of nuclear acceptor sites with in vitro gene transcription. #318. Presented at the 62nd Annual Endocrine Society Meeting, Washington, June 1980

6. Taylor RN, Smith RG and Corriere JN, Jr. Heterogeneity of steroid binding in kidney cytosol. #417. Presented at the 76th Annual American Urological Association Meeting, Boston, May 1981

7. Smith RG, Taylor RN and Beck JC. Properties of the two chick oviduct estrogen receptors. #623. Presented at the 64th Annual Endocrine Society Meeting, San Francisco, June 1982

8. Dandekar P, Martin M, Andreyko J, Marshall L, Taylor R, Dumesic D, Monroe S and Glass R. Polyovular follicles in IVF patients. #149. Presented at the 42nd Annual American Fertility Society Meeting, Toronto, September 1986

9. Martin M, Andreyko J, Marshall L, Dumesic D, Taylor R and Glass R. The role of washed intrauterine insemination in the treatment of infertility. #321. Presented at the 42nd Annual American Fertility Society Meeting, Toronto, September 1986

10. Taylor RN and Williams LT. Coordinated expression of PDGF and PDGF-receptor genes during human placental development. #316, 1987. Presented at the 69th Annual Endocrine Society Meeting, Indianapolis, June 1987

11. Rodgers GM, Taylor RN and Roberts JM. Preeclampsia is associated with a serum factor which damages human endothelial cells. Clin Res 36:187A, 1988. Presented at the Western Society for Clinical Investigation, Carmel, February 1988

12. Musci TJ, Roberts JM, Rodgers GM and Taylor RN. Mitogenic activity is increased in the sera of preeclamptic women prior to delivery. #300, 1988. Presented at the 35th Annual Meeting of the Society for Gynecologic Investigation, Baltimore, March 1988

13. Taylor RN. Diminished expression of the platelet-derived growth factor receptor gene in human gestational trophoblastic neoplasia. #206, Presented at the 35th Annual Meeting of the Society for Gynecologic Investigation, Baltimore, March 1988

14. Taylor RN, Wilcox JN, Goldsmith PC and Williams LT. In situ localization of PDGF and PDGF-receptor in the midtrimester human placenta. J Cell Biol 107:479A, 1988. Presented at the Joint American Society of Cell Biology and the American Society of Biochemistry and Molecular Biology Meeting, San Francisco, February 1989

15. Taylor RN, Musci TJ, Rodgers GM and Roberts JM. Predelivery preeclamptic sera stimulate platelet-derived growth factor mRNA expression in human endothelial cell cultures. #211. Presented at the 36th Annual Meeting of the Society for Gynecologic Investigation, San Diego, March 1989

16. Taylor RN, Newman E, Conn M and Glasser SR. Forskolin induces the biochemical and morphological differentiation of human trophoblast cells in vitro. #521. Presented at the 71st Annual Endocrine Society Meeting, Seattle, June 1989


17. Kratzer PG and Taylor RN. Human chorionic gonadotropin (hCG) regulation of the corpus luteum in ectopic pregnancy. #P-101. Presented at the 45th Annual American Fertility Society Meeting, San Francisco, November1989

18. Taylor RN, Heilbron DC, Jazayeri M, Perry J and Roberts JM. Longitudinal, prospective analysis of growth factor activity in the blood of women predestined to develop preeclampsia. #531. Presented at the 37th Annual Meeting of the Society for Gynecologic Investigation, St. Louis, March 1990

19. Taylor RN, Adlahka RC, Teng NNH and Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. #1507. Presented at the 72nd Annual Meeting of the Endocrine Society, Atlanta, June 1990

20. Malee MP, Taylor RN and Roberts JM. Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia. Am J Obstet Gynecol 164:82A, 1991. Presented at the 11th Annual Meeting of the Society of Perinatal Obstetricians, San Francisco, January 1991

21. Friedman SA, Taylor RN, Crombleholme WR, Jones LA, Casal DC and Roberts

JM. Elevated plasma cellular fibronectin concentrations in preeclampsia cannot be attributed to hypertension alone. Am J Obstet Gynecol 164:83A, 1991. Presented at the 11th Annual Meeting of the Society of Perinatal Obstetricians, San Francisco, January 1991

22. Librach CL, Siiteri PK, Fisher SJ and Feigenbaum SL (Spon: Taylor RN). Human placental cytotrophoblast production of interleukin-1 beta (IL-1β) is developmentally regulated and inhibited by glucocorticoids. #294. Presented at the 38th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, March 1991

23. Taylor RN, Casal DC, Jones LA, Varma M and Roberts JM. In vitro release of endothelial cell fibronectin is stimulated by preeclamptic serum. #325. Presented at the 38th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, March 1991

24. Riemer RK and Taylor RN. Stimulation of cAMP production in myometrioid tumor cells antagonizes the mitogenic response to serum. #406. Presented at the 38th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, March 1991

25. Kratzer PG, Golbus MS and Taylor RN. Cytogenetic evidence for enhanced selective miscarriage rate in advancing maternal age. Am J Hum Genet 49 (suppl):1204A, 1991. Presented at the 8th International Congress of Human Genetics, Washington, October 1991

26. Taylor RN, Casal DC, Edep ME and Roberts JM. In vitro endothelial cell dysfunction induced by preeclamptic serum. J Perinat Med 19 (suppl 2):73, 1991. Presented at the 1st International Congress of Perinatal Medicine, Tokyo, November 1991

27. Kilpatrick SJ, Roberts JM, Illsley NP and Taylor RN. Characterization and ontogeny of endothelin receptors in human placenta. #438. Presented at the 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, March 1992

28. de Groot CJM, Friedman SA, Taylor RN and Roberts JM. Characterization of the increased prostacyclin production by human endothelial cells exposed to plasma from preeclamptic women. #133. Presented at the 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, March, 1992

29. Taylor RN. Growth factor receptor signal transduction: Tyrosine kinases. Cellular Signaling Symposium, Abstract book, pp 84-85. Presented at the 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, March 1992

30. Friedman SA, de Groot CJM, Taylor RN and Roberts JM. Do circulating concentrations of fetal fibronectin detect reduced trophoblastic invasion in


preeclamptic pregnancies? #475. Presented at the 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, March 1992

31. Friedman SA, de Groot CJM, Taylor RN and Roberts JM. Plasma cellular fibronectin as a measure of endothelial cell injury in preeclampsia and intrauterine growth retardation. #54. Presented at the 8th World Congress on Hypertension in Pregnancy, Buenos Aires, November 1992

32. de Groot CJM, Friedman SA, Roberts JM and Taylor RN. Extracellular matrix associations modulate human endothelial cell gene expression. #55. Presented at the 8th World Congress on Hypertension in Pregnancy, Buenos Aires, November 1992

33. de Groot CJM, Friedman SA, Taylor RN and Roberts JM. Prostacyclin as an in vitro marker of human endothelial cell activation by plasma from preeclamptic and normal pregnant women. #87, 1992. Presented at the 8th World Congress on Hypertension in Pregnancy, Buenos Aires, November 1992

34. Taylor RN. In vitro characterization of endothelium-mediated vascular function. Proceedings of the 8th World Congress on Hypertension in Pregnancy, p 89, 1992. Presented at the 8th World Congress on Hypertension in Pregnancy, Buenos Aires, November 1992

35. Roberts JM, Friedman SA, de Groot CJM and Taylor RN. Humoral factors activate endothelial cells in preeclampsia. Proceedings of the 8th World Congress on Hypertension in Pregnancy, p 36, 1992. Presented at the 8th World Congress on Hypertension in Pregnancy, Buenos Aires, November 1992

36. Friedman SA, de Groot CJM, Taylor RN and Roberts JM. Review of selected plasma and urinary predictors of preeclampsia. Proceedings of the 8th World Congress on Hypertension in Pregnancy, p 101, 1992. Presented at the 8th World Congress on Hypertension in Pregnancy, Buenos Aires, November 1992

37. Kratzer PG, Golbus MS, Schriock EA, Norton M, Monroe SE and Taylor RN. First trimester aneuploidy screening using multiple biochemical serum markers. Am J Hum Genet 51 (suppl):1057A, 1992. Presented at the 42nd Annual Meeting of the American Society of Human Genetics, San Francisco, November 1992

38. Taylor RN, Varma M and Lanyi S. Plasma insulin-like growth factor binding protein (IGFBP)-3 in preeclampsia. Am J Obstet Gynecol 168:319A, 1992. Presented at the 13th Annual Meeting of the Society of Perinatal Obstetricians, San Francisco, February 1993

39. Ryan IP, Schriock ED and Taylor RN. Establishment of an in vitro model to study the pathogenesis of endometriosis. #S56. Presented at the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto, March 1993

40. Khorram O, Taylor RN, Ryan IP, Schall TJ and Landers DV. Peritoneal fluid concentrations of the novel cytokine RANTES correlate with the severity of endometriosis. #P-294. Presented at the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto, March 1993

41. Sudhir K, Kumar S, de Groot CJM, Amidon TM, Klinski C, Lau D, Taylor RN, Chatterjee K and De Marco T. Endothelin-1 concentrations are elevated in cardiac transplant recipients and correlate inversely with time from transplantation. #P-1-53. Presented at the 42nd Annual Meeting of the American College of Cardiology, Anaheim, March 1993

42. Baker VL, Murai JT and Taylor RN. Epidermal growth factor and phorbol ester appear to amplify chorionic gonadotropin-β production in transformed human trophoblast cells by increasing EGF-receptors. #255. Presented at the 75th Annual Endocrine Society Meeting, Las Vegas, June 1993

43. Taylor RN, Khorram O, Ryan IP and Landers DV. Cytokine concentrations in peritoneal fluid suggest that monocyte/macrophage chemotaxis plays an important


role in endometriosis. #61. Presented at the 2nd Conference on the Endometrium, Bologna, September 1993

44. Bass KE, Roth I, Taylor RN and Fisher SJ. Growth factor effects on human cytotrophoblast invasion in vitro. Mol Biol Cell 4:251A. Presented at the 33rd Annual American Society for Cell Biology Meeting, New Orleans, December 1993

45. Lim K-H, Rice G and Taylor RN. Plasma type II phospholipase A2 levels are elevated in severe preeclampsia. Am J Obstet Gynecol 170:484A, 1994. Presented at the 14th Annual Meeting of the Society of Perinatal Obstetricians, Las Vegas, February 1994

46. de Groot CJM, O’Brien TJ and Taylor RN. Midpregnancy plasma IGFBP-1 and CA-125 concentrations reflect impaired trophoblastic invasion of decidual stroma in women destined to develop preeclampsia. #O-97. Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 1994

47. Ryan IP, Tseng JF, Schriock ED, Khorram O, Landers DV and Taylor RN. Interleukin (IL)-8 concentrations are elevated in peritoneal fluid of women with endometriosis. #P-39. Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 1994

48. Arbogast BW, Leeper SC, Merrick RD, Olive KE and Taylor RN. Plasma triglyceride toxicity and pI 5.6 albumin cytoprotective activity provide mechanisms for endothelial cell dysfunction in preeclampsia. #P382. Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 1994

49. Paidas MJ, Taylor RN, Schwartzman H, Saleh AA, Alvarez M and Lockwood CJ. Third trimester type 1 and type 2 plasminogen activator inhibitor (PAI 1, PAI 2) levels are associated with preeclampsia. #O-148. Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 1994

50. Paidas MJ, Taylor RN, Schwartzman H, Saleh AA, Alvarez M and Lockwood CJ. Third trimester fetal fibronectin (fFN) levels are associated with the development of preeclampsia (PE). #P-392. Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 1994

51. Lim K-H, Bass K, Chun S-H, Damsky C and Fisher S (Spon: Taylor RN). Differentiation of invasive cytotrophoblasts in normal and abnormal pregnancy. #O-42. Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 1994

52. Taylor RN. Cytokines, the immune response and infertility. NIH Workshop, Alternatives to Hysterectomy: Bench to Bedside, NIH Campus, Bethesda, May 1994

53. Baker VL, Murai JT and Taylor RN. Phorbol ester stimulates hCG- production in human choriocarcinoma cells by down-regulation of protein kinase C activity. #800. Presented at the 76th Annual Endocrine Society Meeting, Anaheim, June 1994

54. Tseng JF, Ryan IP, Murai JT, Milam TD, Landers DV and Taylor RN. Estrogen regulation and interleukin-6 response in stromal cells cultured from human endometrium and endometriosis. #1792. Presented at the 76th Annual Endocrine Society Meeting, Anaheim, June 1994

55. Shifren JL, Tseng JF, Zaloudek CJ, Mesiano S, Jaffe RB and Taylor RN. Vascular endothelial growth factor mRNA and peptide expression in the cycling human endometrium. #192. Presented at the 76th Annual Endocrine Society Meeting, Anaheim, June 1994

56. Baker VL, Chao V, Jazayeri M and Taylor RN. Epidermal growth factor is a potent mitogen for human vascular smooth muscle cells. #O-48. Presented at the 50th Annual Meeting of the American Fertility Society, San Antonio, November 1994

57. Shifren JL, Tseng JF, Ryan IP, Ferrara N, Jaffe RB and Taylor RN. Vascular endothelial growth factor (VEGF) is regulated by estrogen in endometrial cells and may play a role in the pathogenesis of endometriosis. #O-59. Presented at the 50th Annual Meeting of the American Fertility Society, San Antonio, November 1994


58. Lockwood CJ, Paidas MJ, Lapinski R and Taylor RN. Elevated maternal plasma β2-glycoprotein-1 (β2GP1) values precede the clinical onset of preeclampsia. Am J Obstet Gynecol 172:427A, 1995. Presented at the 15th Annual Meeting of the Society of Perinatal Obstetricians, Atlanta, January 1995

59. Shifren JL, Lee J, Mesiano S, Taylor RN and Jaffe RB. ACTH increases vascular endothelial growth factor expression in human fetal adrenal cortical cells. J Soc Gynecol Invest 3 (#2 suppl):131, 1996. Presented at the 43rd Annual Meeting of the Society for Gynecologic Investigation, Philadelphia, March 1996

60. Ryan IP, Tseng JF, Schriock ED, Khorram O, Schall TJ, Landers DV and Taylor RN. RANTES chemokine expression is up-regulated in stromal cells cultured from human endometriosis tissues. J Soc Gynecol Invest 3 (#2 suppl):32, 1996. Presented at the 43rd Annual Meeting of the Society for Gynecologic Investigation, Philadelphia, March 1996

61. Taylor RN. Endothelial cell dysfunction in preeclampsia. Presented at the IX World Congress on Human Reproduction, Philadelphia, May 1996

62. Muzykanskiy E, Murai JT, Perry J and Taylor RN. Indicators of altered lipid metabolism correlate with the development of preeclampsia. #OR4-4. Presented at the 10th International Congress of Endocrinology, San Francisco, June 1996

63. Hornung D, Ryan I, Nelson P, Krensky A and Taylor RN. Immunolocalization and expression of the chemokine RANTES in human endometrial and endometriosis tissues. #OR-67-5. Presented at the 10th International Congress of Endocrinology, San Francisco, June 1996

64. Taylor RN. Immunological aspects of preeclampsia. Presented at the 16th Annual American Society for Reproductive Immunology Meeting, Knoxville, June 1996

65. Taylor RN. Cytokine networks in endometriosis. Presented at the 3rd International Conference on the Uterus: Endometrium and Myometrium. New York, October 1996

66. Hornung D, Tseng JF, Ryan IP, Chao VA, Nelson PJ, Schriock ED and Taylor RN. Transcriptional regulation of RANTES gene expression in human endometrial cells. #O-9. Presented at the 52nd Annual Meeting of the American Society for Reproductive Medicine, Boston, November 1996

67. Tseng JF, Ryan IP, Milam TD, Murai JT, Schriock ED, Landers DV and Taylor RN. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. Ob/Gyn Digest 7:31-32, 1996

68. Hornung D, Lebovic DI, Shifren JL, Vigne J-L and Taylor RN. Vectorial secretion of vascular endothelial growth factor (VEGF) by polarized human endometrial epithelial cells. J Soc Gynecol Invest 4 (#1 suppl):637, 1997. Presented at the 44th Annual Meeting of the Society for Gynecologic Investigation, San Diego, March 1997

69. Burlingame J, Musci TJ, Taylor RN and Strauss A. Long chain 3-acyl coA fatty acid dehydrogenase G1528C mutations: Association with acute fatty liver of pregnancy but not with preeclampsia. J Soc Gynecol Invest 4 (#1 suppl):667, 1997. Presented at the 44th Annual Meeting of the Society for Gynecologic Investigation, San Diego, March 1997

70. Bentzien F, Vigne J-L, Weiner RI and Taylor RN. Potential role of cathepsin D in the formation of antiangiogenic fragments of prolactin in the human endometrium. #P1-33. Presented at the 79th Annual Endocrine Society Meeting, Minneapolis, June 1997

71. Vigne J-L, Murai JT, Arbogast BW, Jia W, Fisher SJ and Taylor RN. Elevated levels of non-esterified fatty acids (NEFA) in severe preeclampsia shift the pI of plasma albumin and reduce its cytoprotective activity. #P1-394. Presented at the 79th Annual Endocrine Society Meeting, Minneapolis, June 1997

72. Hornung D, Chao VA, Schriock ED, Kiesel L and Taylor RN. Cellular localization and time course of RANTES gene expression in human endometrial and endometriosis


tissues. Hum Reprod 12 (Abst. book 1): #O-229, 1997. Presented at the European Society of Human Reproduction and Embryology Meeting, Edinburgh, June 1997

73. Taylor RN. Endometrial function inside and outside the uterus. Presented at the 9th Annual NICHD Aspen Conference on Maternal-Fetal-Neonatal-Reproductive Medicine, Aspen, August 1997

74. Lebovic DI, Ryan IP and Taylor RN. Induction of vascular endothelial growth factor and interleukin-6 expression in human endometriosis stromal cell cultures by interleukin-1β. #O-30. Presented at the 53rd Annual Meeting of the American Society for Reproductive Medicine, Cincinnati, October 1997

75. Hornung D, Vigne J-L and Taylor RN. RANTES derived from normal endometrial and endometriosis stromal cells has altered bio- to immunoactivity. J Soc Gynecol Invest 5 (#1 suppl):18, 1998. Presented at the 45th Annual Meeting of the Society for Gynecologic Investigation, Atlanta, March 1998

76. Hornung D, Kiesel L and Taylor RN. VEGF secretion by human endometrial epithelial cells in culture on semipermeable membranes. Hum Reprod 13 (Abst. book 1): #O-065, 1998. Presented at the European Society of Human Reproduction and Embryology Meeting, Göteborg, June 1998

77. Bentzien F, Taylor RN and Weiner RI. Changes in 16K hPRL binding levels in human placenta during gestation. #P3-467. Presented at the 80th Annual Endocrine Society Meeting, New Orleans, June 1998

78. Taylor RN, Ryan IP, Tseng JF, Shifren JL, Hornung D and Lebovic DI. Ovarian steroids and angiogenesis. #87. Presented at the VI World Congress on Endometriosis, Québec City, July 1998

79. Lundeen SG, Lebovic DI, Carver JM, Taylor RN and Winneker RC. Establishment and characterization of endometriosis stromal cell lines with an extended life-span. #254. 2nd place prize abstract. Presented at the VI World Congress on Endometriosis, Québec City, July 1998

80. Lebovic DI, Bentzien F, Garrett EN and Taylor RN. Interleukin (IL)-1β–inducible proteins from human endometriosis stromal cells have angiogenic activity. #65. Presented at the VI World Congress on Endometriosis, Québec City, July 1998

81. Hornung D, Sotlar K, Dohrn K, Kiesel L and Taylor RN. Localization of eotaxin in normal endometrium and endometriosis tissues. #25. Presented at the VI World Congress on Endometriosis, Québec City, July 1998

82. Lebovic DI, Chao VA and Taylor RN. Increased responsiveness of human endometriosis stromal cell cultures to interleukin (IL)-1β appears to be mediated by up-regulation of IL-1 type I receptors. #O-172. Presented at the 54th Annual Meeting of the American Society for Reproductive Medicine, San Francisco, October 1998

83. Hornung D, Taylor RN, Wallwiener D and Kiesel L. Immunoactivity of RANTES from endometriosis and endometrial stromal cells demonstrated by Boyden chamber assays. #5. Presented at the 7th Congress of the European Society for Gynaecological Endoscopy, Lausanne, December 1998

84. Lebovic DI, Chao VA and Taylor RN. Interleukin (IL)-1β stimulates RANTES gene expression in human endometrial stromal cells. J Soc Gynecol Invest 6 (#1 suppl):108, 1999. Presented at the 46th Annual Meeting of the Society for Gynecologic Investigation, Atlanta, March 1999

85. Sawaya GF, Kerlikowske K, Lee N, Gildengorin G and Washington AE (Spon: Taylor RN). What is the optimal cervical cancer rescreening interval? J Soc Gynecol Invest 6 (#1 suppl):97, 1999. Presented at the 46th Annual Meeting of the Society for Gynecologic Investigation, Atlanta, March 1999

86. Vigne J-L, Zhang P, Lebovic DI, Mueller MD, Milgrom E and Taylor RN. Regulation of glycodelin gene expression by progesterone and relaxin in human endometrial cells.


#P2-069. Presented at the 81st Annual Endocrine Society Meeting, San Diego, June 1999

87. Taylor RN. Steroids, cytokines and prostanoids in endometrial angiogenesis. #26. Presented at the 5th International Congress on the Cell Biology of Reproduction, Cambridge, UK, July 1999

88. Taylor RN, Vigne J-L, Zhang P, Hoang P, Mueller MD and Lebovic DI. Effect of progestins and relaxin on glycodelin gene expression in human endometrial cells. Presented at the 18th Annual American Gynecological and Obstetrical Society, Carlsbad, September 1999

89. Mueller MD, Lebovic DI, Vigne J-L, Leitman DC and Taylor RN. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β in human endometrial cells. #O-73. Presented at the 55th Annual Meeting of the American Society for Reproductive Medicine, Toronto, September 1999

90. Ryan IP, Shifren JL, Lebovic DI, Korn AP, Zaloudek CJ, Darney PD and Taylor RN. Histological features of endometrial biopsies in patients using parenteral progestin contraceptives. #P-374. Presented at the 55th Annual Meeting of the American Society for Reproductive Medicine, Toronto, September 1999

91. Greenblatt RM, Ameli N, Grant RM, Bacchetti P and Taylor RN. Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women. #O-123. Presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), American Society for Microbiology, San Francisco, September 1999

92. Lebovic DI, Mueller MD and Taylor RN. Evidence implicating macrophage-derived interleukin (IL)-1β in the pathophysiology of endometriosis. J Am Assoc Gynecol Lap 6 (#3 suppl):S73, 1999. Prize poster presented at the 28th Annual Meeting of the American Association of Gynecological Laparoscopists, Las Vegas, November 1999

93. Lebovic DI, Chao VA and Taylor RN. Nuclear factor κB (NFκB) mediates interleukin-1β (IL-1β)-inducible RANTES gene expression in human endometrial stromal cells. J Soc Gynecol Invest 7 (#1 suppl):228, 2000. Presented at the 47th Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 2000

94. Mueller MD, Lebovic DI, Minchenko AG, Leitman DC and Taylor RN. Vascular endothelial growth factor (VEGF) gene transcription is regulated by estrogen receptor α in human endometrial cells. J Soc Gynecol Invest 7 (#1 suppl):925, 2000. Presented at the 47th Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 2000

95. Waite LL, Zhao Y, Lim K-H and Taylor RN. Peroxisome proliferator activated receptor-γ expression and action in human placenta. J Soc Gynecol Invest 7 (#1 suppl):351, 2000. Presented at the 47th Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 2000

96. Taylor RN, Mueller MD and Lebovic DI. Angiogenesis in human endometrium and endometriosis. Presented at the International Conference on the Female Reproductive Tract, Frauenwörth, May 2000

97. Taylor RN. Genomic and proteomic approaches to cellular pathology. #VI. Presented at the VII World Congress on Endometriosis, London, May 2000

98. Lundeen SG, Lebovic DI, Carver JM, Meade EH Jr, Winneker RC and Taylor RN. Differential display PCR analysis of gene expression in eutopic and ectopic endometrial tissues. #27. Presented at the VII World Congress on Endometriosis, London, May 2000

99. Hornung D, Vigne J-L, Wallwiener D, Kiesel L and Taylor RN. Monocyte chemotaxis is induced by RANTES and inhibited by glycodelin in peritoneal fluid of women with endometriosis. #146. Presented at the VII World Congress on Endometriosis, London, May 2000


100. Vigne J-L, Hornung D and Taylor RN. Human decidual glycodelin is a potent inhibitor of monocyte migration. #2291. Presented at the 82nd Annual Endocrine Society Meeting, Toronto, June 2000

101. North RA, Taylor RS, Arbogast BW, Arbogast VK and Taylor RN. The endothelial protective toxicity preventing activity of albumin is reduced in preeclampsia but not small for gestational age pregnancies. #O-45. Presented at the 12th World Congress on Hypertension in Pregnancy, Paris, July 2000

102. Taylor RN, Taylor RS, Grimwood J, McMaster MT, Fisher SJ and North RA. Angiogenic growth factors in pregnancies complicated by pre-eclampsia (PE) and intrauterine fœtal growth restriction (IUGR). #P-54. Presented at the 12th World Congress on Hypertension in Pregnancy, Paris, July 2000

103. Hornung D, Fujii E, Lim K-H, Vigne J-L and Taylor RN. HLA-G does not mediate the natural killer cell suppression associated with endometriosis. #P-70. Presented at the 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, October 2000

104. Mueller MD, Lebovic DI and Taylor RN. Epithelial neutrophil-activating protein 78 (ENA-78) is elevated in the peritoneal fluid of patients with endometriosis. #O-58. Presented at the 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, October 2000

105. Taylor RN. Endometriosis: inflammation and infertility. Plenary Session #28. Presented at the 8th World Congress of Gynecological Endocrinology, Florence, December 2000

106. Lebovic DI, Baldocchi RA, Mueller MD and Taylor RN. Endometriosis genomics: Altered expression of a cell-cycle suppressor gene, Tob, in endometriotic cells by cDNA array analyses. #78. Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, Toronto, March 2001

107. Mueller MD, Pritts E, Leitman DC and Taylor RN. Endometrial angiogenic activity of tamoxifen in vitro and in vivo. #439. Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, Toronto, March 2001

108. Yap OSW, Udo E, Lebovic DI, Leitman DC and Taylor RN. Androgen receptor-mediated inhibition of TNF-α gene expression. #592. Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, Toronto, March 2001

109. Waite LL, Ricke EA and Taylor RN. Characterization of PPAR activating factors in the serum of pregnant women. #742. Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, Toronto, March 2001

110. Tyurin VA, Liu S-X, Tyurina YY, Hubel CA, Roberts JM, Taylor RN, Kagan VE. S-Nitrosylation of albumin is increased in preeclampsia. #22. Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, Toronto, March 2001

111. Taylor RN. Angiogenic factors in endometriosis. Presented at NICHD Conference on Endometriosis: Emerging Research and Intervention Strategies, pp. 33-34, Bethesda, April, 2001

112. Giudice LC, Kao LC, Yang J, Taylor RN, Osteen K, Lessey BD. Global gene expression profiling of human endometrium from women with endometriosis using Genechip® microarray technology (abstract). NICHD Conference on Endometriosis: Emerging Research and Intervention Strategies, pp 62-23, Bethesda, April 2001

113. Taylor RN. Endometriosis: an inflammatory paradigm. #3. Presented at the 1st Nordic Congress on Endometriosis, Stockholm, April 2001

114. Hornung D, Waite LL, Ricke EA, Bentzien F, Wallwiener D and Taylor RN. PPAR-α activation by peritoneal fluid from patients with endometriosis is associated with monocyte chemotaxis. #21. Presented at the NIH Specialized Cooperative Centers Program in Reproduction Research Meeting. NICHD, Bethesda, May 2001


115. Mann SE, Ricke EA, Torres E, Wang B, Verkman AS, and Taylor RN. Expression and localization of aquaporin-1 in human fetal membranes. O-4-2. Presented at the XXXIVth International Congress of Physiological Sciences. Christchurch, August 2001

116. Bolden-Kramer RS, Waite LL and Taylor RN. Preeclampsia and the role of peroxisome proliferator-activated receptors. Presented at the Annual 2001 UCSF Science and Health Education Partnership High School Student Internship Program, August 2001

117. Zhao D, Lebovic DI, Hornung D and Taylor RN. Inhibition of RANTES gene transcription by medroxyprogesterone acetate (MPA). #O173. Presented at the 57th Annual Meeting of the American Society for Reproductive Medicine, Orlando, October 2001

118. Taylor RN, Lebovic DI and Hornung D. Chemokine expression in endometrium and endometriosis. Presented at the 9th World Congress of Gynecological Endocrinology, Hong Kong, December 2001

119. Zhao D, Pritts EA, Hornung D and Taylor RN. Epithelial-stromal interactions induce RANTES expression in endometriosis. Fertil Steril 77 (suppl 1) S26, 2002. Selected as the 1st Place Prize Paper, VIIIth World Congress on Endometriosis, San Diego, February 2002

120. Zhao D, Pritts EA, Chao VA, Savouret J-F and Taylor RN. Dioxin stimulates chemokine production in an in vitro model of endometriosis. Fertil Steril 77 (suppl 1) S9, 2002. Presented at the VIIIth World Congress on Endometriosis, San Diego, February 2002

121. Pritts EA, Zhao D, Sohn S and Taylor RN. Peroxisome-proliferator activated receptor (PPAR)-γ ligands inhibit RANTES transcription and translation in human endometrial stromal cells. Fertil Steril 77 (suppl 1) S41, 2002. Presented at the VIIIth World Congress on Endometriosis, San Diego, February 2002

122. Pritts EA, Bentzien F, Zhao D, Hornung D and Taylor RN. RANTES attracts and activates human monocytes through multiple signaling pathways. #283. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, March 2002

123. Mann SE, Ricke EA, Yang BA, Verkman AS and Taylor RN. The preservation of amniotic fluid volume in aquaporin 1 knockout mice. #705. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, March 2002

124. Waite LL, Ricke EA and Taylor RN. Activators of peroxisome proliferator-activated receptors (PPARs) are reduced in sera from women with early onset preeclampsia (PE). #593. President’s Prize paper presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, March 2002

125. Easwaran V, Lee S-H, Guo L, Inge L, Goldbeck S, Garcia P, Randazzo F, Reinhard C, Aukerman S, Gundel R, Escobedo J, Taylor RN and Fantl WJ. β-Catenin regulates vascular endothelial growth factor (VEGF-A) expression in colon cancer. Presented at the Keystone Conference on Wnt and β-Catenin Signaling in Development and Disease, Taos, March 2002

126. Pritts EA, Zhao D, Sohn SH, Chao VA, Ricke EA, Waite LL and Taylor RN. Peroxisome-proliferator activated receptor (PPAR)-γ ligands inhibit RANTES production by human endometriotic stromal cells. #P2-273. Presented at the 84th Annual Meeting of the Endocrine Society, San Francisco, June 2002

127. Giudice LC, Kao LC, Lessey B, Taylor RN and Osteen K. Gene discovery in human endometrium: a peek into the window of implantation. #S23-3. Presented at the 84th Annual Meeting of the Endocrine Society, San Francisco, June 2002

128. Hornung D, Bentzien F, Wallwiener D and Taylor RN. Thiazolidinedione (TZD) treatment of endometriosis-associated inflammation. Hum Reprod 17:26, 2002, O-


071. Presented at the18th Annual Meeting of the European Society of Human Reproduction and Embryology, Vienna, June/July 2002

129. Pritts EA, Ryan IP, Mueller MD, Zaloudek CJ, Darney PD and Taylor RN. Angiogenic and proliferative effects of Norplant® on endometrial histology. #O-68. Presented at the 58th Annual Meeting of the American Society for Reproductive Medicine, Seattle, October 2002

130. Waite LL, Louie RE and Taylor RN. Decreased PPAR-γ activation is specific to preeclampsia and occurs before onset of symptoms. #570. Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, Washington, March 2003

131. Tyurin VA, Gandley RE, Harger G, Gryzunov, Vigne JL, Hubel CA, Taylor RN and Kagan VE. Fatty acids induce redox-cycling and denitrosylation of albumin: relevance to endothelial dysfunction in preeclampsia. #576. Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, Washington, March 2003

132. Yap OSW, Nedachi T, Taylor RN, Teng NN and Conti M. Steroid receptors and their non-genomic mechanism of action in xenopus laevis oocyte maturation. #351. Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, Washington, March 2003

133. Mann SE, Dvorak N and Taylor RN. Aquaporins and human fetal membranes: There are more than one. #211. Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, Washington, March 2003

134. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K and Lessey BA and Giudice LC. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. S-9. Presented at the NICHD WRHR Scholars’ Research Symposium, Bethesda, March 2003

135. Tyurin VA, Gandley RE, Hubel CA, Taylor RN, Kagan VE. Enhancement of NO release from S-nitrosoalbumin by fatty acids: Relevance to oxidative/nitrosative stress in preeclampsia. #161 Toxicol Sci 72 (suppl 1): 33-34, 2003. Presented at the 42nd Annual Meeting of the Society of Toxicology, Salt Lake City, March 2003

136. Giudice LC, Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K and Lessey BA. Progesterone-regulated genes and endometriosis: a genomics approach. Presented at the 19th Annual Meeting of the European Society for Human Reproduction and Embryology, Madrid, June 2003

137. Ecker J, Karumanchi A, Robert J, Taylor R, Levine R and Thadhani R. First trimester Placental Growth Factor, sFlt-1 and risk for pre-eclampsia. #14. Presented at the 24h Annual Meeting of the Society for Maternal-Fetal Medicine, New Orleans, February 2004

138. Mann SE, Dvorak N and Taylor RN. Fetal membrane water permeability is decreased in polyhydramnios: A new explanation for an old problem. #504. Presented at the 24h Annual Meeting of the Society for Maternal-Fetal Medicine, New Orleans, February 2004

139. Taylor RN. Placental angiogenesis in physiology and pathophysiology. #PS33. Gynecol Endocrinol 18 (suppl 1): 99, 2004. Presented at the 11th World Congress of Gynecologic Endocrinology, Florence, February 2004

140. Hornung D, Dogan S, Buerhing H-J, Klingel K, Diedrich K and Taylor RN. Expression and regulation of CCR-1 in peritoneal macrophages of patients with and without endometriosis. Presented at the 51st Annual Meeting of the Society for Gynecologic Investigation, Houston, March 2004

141. Krikun G, Schatz F, Sakkas D, Taylor R, Critchley H and Lockwood C. In vitro and in vivo quantitation of steroid receptor mRNAs in endometrial endothelial cells. #205.


Presented at the 51st Annual Meeting of the Society for Gynecologic Investigation, Houston, March 2004

142. Wieser F, Vigne J-L, Tee M-K, Chao V and Taylor RN. Phorbol dibutyrate (PDB) induces apoptosis in an epithelial endometrial adenocarcinoma cell line (HEC-1B). #953. Presented at the 51stAnnual Meeting of the Society for Gynecologic Investigation, Houston, March 2004

143. Lane DE, Cedars MI, Dandekar P and Taylor RN. A positive correlation between human serum and follicular fluid insulin levels. #189. Presented at the 51stAnnual Meeting of the Society for Gynecologic Investigation, Houston, March 2004

144. Waite LL, Duarte MA, Jr and Taylor RN. The pregnancy PPAR activator is regulated by albumin binding; implications for preeclampsia. #348. Presented at the 51st Annual Meeting of the Society for Gynecologic Investigation, Houston, March 2004

145. Tyurin VA, Zhao Q, Jiang J, Borisenko GG, Gandley RE, Tyurina YY, Bayir H, Kapralov AA, Shvedova AA, Komarov AM, Hubel CA, Taylor RN, Stoyanovsky DA and Kagan VE. Assessment of S-nitrosothiols in biological fluids: Content of S-nitrosothiols in plasma. #1998. Toxicol Sci 78 (suppl 1): 411, 2004. Presented at the 43nd Annual Meeting of the Society of Toxicology, Baltimore, March 2004

146. Tee M-K, Vigne J-L and Taylor RN. All-trans retinoic acid inhibits VEGF expression in promyelocytic cells. #P1-169. Presented at the 86th Annual Meeting of the Endocrine Society, New Orleans, June 2004

147. Wieser F, Vigne J-L, Chao V and Taylor RN. Sulindac induces apoptosis in TNF-α treated endometrial adenocarcinoma cells. #P2-309. Presented at the 86th Annual Meeting of the Endocrine Society, New Orleans, June 2004

148. Mann SE, Dvorak N and Taylor RN. Changes in aquaporin 1 expression affect amniotic fluid volume. #456. Presented at the 25h Annual Meeting of the Society for Maternal-Fetal Medicine, Reno, February 2005

149. Vigne J-L, Mueller MD, Streit M, Raio L, Dreher E, Bersinger NA and Taylor RN. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases glycodelin gene and protein expression in human endometrium. #308. Presented at the 52nd Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, March 2005

150. Wieser F, Vigne J-L, Djalali S and Taylor RN. Sulindac suppresses NF(nuclear factor)κB activation, RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. #311. Presented at the 52nd Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, March 2005

151. Rinaudo P, Schultz RM (Spon: Taylor RN). Effects of different oxygen concentrations on global patterns of gene expression in mouse preimplantation embryos. #329. Presented at the 52nd Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, March 2005

approved by COC 12/01/97revised in order only 7/15/98

STANDARD CURRICULUM VITÃ† FORMAT.doc.doc

Health & Medicine

Transcript of STANDARD CURRICULUM VITÃ† FORMAT.doc.doc